US20050234518A1 - Collecting activity and sleep quality information via a medical device - Google Patents

Collecting activity and sleep quality information via a medical device Download PDF

Info

Publication number
US20050234518A1
US20050234518A1 US11081857 US8185705A US2005234518A1 US 20050234518 A1 US20050234518 A1 US 20050234518A1 US 11081857 US11081857 US 11081857 US 8185705 A US8185705 A US 8185705A US 2005234518 A1 US2005234518 A1 US 2005234518A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
patient
activity
sleep
physiological parameters
plurality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11081857
Inventor
Kenneth Heruth
Keith Miesel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1116Determining posture transitions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1118Determining activity level
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4815Sleep quality
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36135Control systems using physiological parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/45For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4519Muscles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6825Hand
    • A61B5/6826Finger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36542Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by body motion, e.g. acceleration

Abstract

A device, such as an implantable medical device (IMD), programming device, or other computing device determines when a patient is attempting to sleep. When the device determines that the patient is attempting to sleep, the device determines values for one or more metrics that indicate the quality of a patient's sleep based on at least one physiological parameter of the patient. When the device determines that the patient is not attempting to sleep, the device periodically determines activity levels of the patient. Activity metric values may be determined based on the determined activity levels. A clinician may use sleep quality information and patient activity information presented by a programming device to, for example, evaluate the effectiveness of therapy delivered to the patient by a medical device.

Description

  • This application is a continuation-in-part of U.S. patent application Ser. No. 10/825,955, filed Apr. 15, 2004, which claims the benefit of U.S. Provisional Application No. 60/553,785, filed Mar. 16, 2004. The entire content of both applications is incorporated herein by reference.
  • TECHNICAL FIELD
  • The invention relates to medical devices and, more particularly, to medical devices that monitor physiological parameters.
  • BACKGROUND
  • In some cases, an ailment may affect the quality of a patient's sleep and/or affect the patient's activity level. For example, chronic pain may cause a patient to have difficulty falling asleep, disturb the patient's sleep, e.g., cause the patient to wake, and prevent the patient from achieving deeper sleep states, such as one or more of the nonrapid eye movement (NREM) sleep states. Chronic pain may also cause a patient to avoid particular activities, or activity in general, where such activities increase the pain experienced by the patient. Other ailments that may negatively affect patient sleep quality and patient activity level include movement disorders, and congestive heart failure. In some cases, these ailments are treated via an implantable medical device (IMD), such as an implantable stimulator or drug delivery device.
  • Further, in some cases, poor sleep quality may increase the symptoms experienced by a patient due to an ailment. For example, poor sleep quality has been linked to increased pain symptoms in chronic pain patients. The link between poor sleep quality and increased symptoms is not limited to ailments that negatively impact sleep quality, such as those listed above. Nonetheless, the condition of a patient with such an ailment may progressively worsen when symptoms disturb sleep quality, which in turn increases the frequency and/or intensity of symptoms. The increased symptoms may, in turn, limit patient activity during the day, and further disturb sleep quality.
  • SUMMARY
  • In general, the invention is directed to techniques for collecting information that relates to patient activity and the quality of patient sleep via a medical device, such as an implantable medical device (IMD). The medical device, or another device, determines whether to collect activity or sleep quality information by determining whether the patient is attempting to sleep. Activity and sleep quality information collected by the device may be presented to a user, such as a clinician, and used to, for example, evaluate the effectiveness of a therapy delivered to the patient by the medical device. For example, the activity and sleep quality information may be associated with different therapy parameter sets used by the medical device to deliver therapy to the patient, permitting a user to evaluate relative efficacy of the therapy parameter sets.
  • The device may determine that the patient is attempting to sleep in a variety of ways. For example, the device may receive an indication from the patient that the patient is trying to fall asleep, e.g., via a patient programming device in embodiments in which the medical device determines whether the patient is attempting to sleep and is an implantable medical device. In other embodiments, the device may monitor the activity level of the patient, and identify the time that the patient is attempting to sleep by determining whether the patient has remained inactive for a threshold period of time and identifying the time at which the patient became inactive. In still other embodiments, the device may monitor patient posture, and identify the time when the patient is recumbent, e.g., lying down, as the time when the patient is attempting to fall asleep. In these embodiments, the device may also monitor patient activity, and confirm that the patient is attempting to sleep based on the patient's activity level.
  • As another example, the device may determine the time at which the patient begins attempting to fall asleep based on the level of melatonin within one or more bodily fluids, such as the patient's blood, cerebrospinal fluid (CSF), or interstitial fluid. The device may also determine a melatonin level based on metabolites of melatonin located in the saliva or urine of the patient. Melatonin is a hormone secreted by the pineal gland into the bloodstream and the CSF as a function of exposure of the optic nerve to light, which synchronizes the patient's circadian rhythm. In particular, increased levels of melatonin during evening hours may cause physiological changes in the patient, which, in turn, may cause the patient to attempt to fall asleep. The device may, for example, detect an increase in the level of melatonin, and estimate the time that the patient will attempt to fall asleep based on the detection.
  • When the device determines that the patient is attempting to sleep, the device may determine values for one or more metrics that indicate the quality of a patient's sleep based on at least one monitored physiological parameter of the patient. Example physiological parameters that the device may monitor to determine sleep quality metric values include activity level, posture, heart rate, electrocardiogram (ECG) morphology, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity and tone, core temperature, subcutaneous temperature, arterial blood flow, brain electrical activity, eye motion, and galvanic skin response. In order to monitor one or more of these parameters, the device may include, or be coupled to, one or more sensors, each of which generates a signal as a function of one or more of these physiological parameters. The device may determine a value of one or more sleep quality metrics based on the monitored physiological parameters, and/or the variability of one or more of the monitored physiological parameters.
  • Sleep efficiency and sleep latency are example sleep quality metrics for which a device may determine values. Sleep efficiency may be measured as the percentage of time while the patient is attempting to sleep that the patient is actually asleep, or actually within one of the different sleep states. Sleep latency may be measured as the amount of time between a first time when the patient begins attempting to fall asleep and a second time when the patient falls asleep, and thereby indicates how long a patient requires to fall asleep.
  • The time when the patient begins attempting to fall asleep may be determined in any of the variety of ways identified above. The time at which the patient has fallen asleep may be determined based on any one or more of the other physiological parameters that may be monitored by the medical device as indicated above. For example, a discemable change, e.g., a decrease, in one or more physiological parameters, or the variability of one or more physiological parameters, may indicate that the patient has fallen asleep. In some embodiments, the device determines a sleep probability metric value based on a value of a physiological parameter. In such embodiments, the device compares the sleep probability metric value to a threshold to identify when the patient has fallen asleep. In some embodiments, the medical device determines a plurality of sleep probability metric values based on a value of each of a plurality of physiological parameters, averages or otherwise combines the plurality of sleep probability metric values to provide an overall sleep probability metric value, and compares the overall sleep probability metric value to a threshold to identify the time that the patient falls asleep.
  • Other sleep quality metrics that the device may determine include total time sleeping per day, the amount or percentage of time sleeping during nighttime or daytime hours per day, and the number of apnea and/or arousal events per night. In some embodiments, the device may determine which sleep state the patient is in, e.g., rapid eye movement (REM), or one of the nonrapid eye movement (NREM) states (S1, S2, S3, S4) based on monitored physiological parameters, and the amount of time per day spent in these various sleep states may be determined by the medical device as a sleep quality metric. Because they provide the most “refreshing” type of sleep, the amount of time spent in one or both of the S3 and S4 sleep states, in particular, may be determined as a sleep quality metric. In some embodiments, the device may determine average or median values of one or more sleep quality metrics over greater periods of time, e.g., a week or a month, as the value of the sleep quality metric. Further, in embodiments in which values for a plurality of the sleep quality metrics are determined, the device may determine a value for an overall sleep quality metric based on the values for the plurality of individual sleep quality metrics.
  • When the device determines that the patient is not attempting to sleep, the device periodically determines activity levels of the patient. For example, the device may monitor a signal generated by an accelerometer, a bonded piezoelectric crystal, a mercury switch, or a gyro. In some embodiments, the device may monitor a signal that indicates a physiological parameter of the patient, which in turn varies as a function of patient activity. For example, the device may monitor a signal that indicates the heart rate, ECG morphology, respiration rate, respiratory volume, core temperature, subcutaneous temperature, or muscular activity level of the patient.
  • The device may periodically determine an activity level of the patient based on the one or more signals. In some embodiments, the device periodically determines a number of activity counts based on the one or more signals, and the number of activity counts is stored as the activity level. The number of activity counts may be a number of threshold crossings by a signal generated by an accelerometer or piezoelectric crystal during a sample period, or a number of switch contacts indicated by the signal generated by a mercury switch during a sample period.
  • In some embodiments, the device may periodically determine a heart rate, value of an ECG morphological feature, respiration rate, respiratory volume, and/or muscular activity level of the patient based on one or more signals. The determined values of these parameters may be mean or median values. The device may compare a determined value of such a physiological parameter to one or more thresholds to determine a number of activity counts, which may be stored as a determined activity level. In other embodiments, the device may store the determined physiological parameter value as a determined activity level.
  • The use of activity counts, however, may allow the device to determine an activity level based on a plurality of signals. For example, the device may determine a first number of activity counts based on a sample of an accelerometer signal and a second number of activity counts based on a heart rate determined at the time the accelerometer signal was sampled. The device may determine an activity level by calculating the sum or average, which may be a weighted sum or average, of first and second activity counts.
  • The device may determine a value of one or more activity metrics based on determined activity levels. An activity metric value may be, for example, a mean or median activity level, such as an average number of activity counts per unit time. In other embodiments, an activity metric value may be chosen from a predetermined scale of activity metric values based on comparison of a mean or median activity level to one or more threshold values. The scale may be numeric, such as activity metric values from 1-10, or qualitative, such as low, medium or high activity.
  • In some embodiments, a number of collected activity levels are compared with one or more thresholds, and percentages of time above and/or below the thresholds are determined as one or more activity metric values. In other embodiments, a number of collected activity levels are compared with one or more thresholds, and an average length of time that consecutively determined activity levels remain above the threshold is determined as an activity metric value.
  • In some embodiments, the device that collects sleep quality and activity information is a medical device delivers a therapy to the patient. At any given time, the medical device delivers the therapy according to a current set of therapy parameters. For example, in embodiments in which the medical device is a neurostimulator, a therapy parameter set may include a pulse amplitude, a pulse width, a pulse rate, a duty cycle, and an indication of active electrodes. Different therapy parameter sets may be selected, e.g., by the patient via a programming device or a the medical device according to a schedule, and parameters of one or more therapy parameter sets may be adjusted by the patient to create new therapy parameter sets. In other words, over time, the medical device delivers the therapy according to a plurality of therapy parameter sets.
  • When the medical device determines a sleep quality metric value or an activity level, the medical device may identify the current therapy parameter set when the value or level is determined, and may associate that value or level with the therapy parameter set. For each available therapy parameter set, the medical device may store a representative value of each of one or more sleep quality metrics in a memory with an indication of the therapy parameter set with which that representative value is associated. A representative value of sleep quality metric for a therapy parameter set may be the mean or median of collected sleep quality metric values that have been associated with that therapy parameter set. For each available therapy parameter set, the medical device may also store one or more associated activity metric values that are determined based on activity levels associated with that therapy parameter set.
  • A programming device according to the invention may be capable of wireless communication with the medical device, and may receive from the medical device information identifying the therapy parameter set, representative sleep quality metric values associated with the plurality of therapy parameter sets, and activity metric values associated with the therapy parameter sets. The programming device may display a list of the therapy parameter sets, which may be ordered according to any of the associated representative sleep quality metric values or activity metric values. A user may select the metric by which the list is ordered. Such a list may be used by a clinician to, for example, identify effective or ineffective therapy parameter sets.
  • In some embodiments, the medical device does not determine whether the patient is attempting to sleep, determine values for sleep quality metrics, determine activity metric values, and/or periodically determine activity levels. Instead, in some embodiments, a computing device, such as a programming device performs one or more of these functions. For example, a programming device may be used to program a medical device, and also receive physiological parameter values, activity levels, and/or samples of an activity signal from the medical device, and determine activity metric values and sleep quality metric values based on the information received from the medical device using any of the techniques described herein with reference to a medical device.
  • In some embodiments, the medical device may associate recorded physiological parameter values, signal samples, and/or activity levels with a current therapy parameter set, and may provide information identifying a plurality of therapy parameter sets and collected information associated with the therapy parameter sets to a programming device or other computing device. In such embodiments, the programming device may determine representative sleep quality metric values and activity metric values associated with the various therapy parameter sets using any of techniques described herein with reference to a medical device. The programming device may receive such information from the medical device in real time, or may interrogate the medical device for information recorded by the medical device over a period of time.
  • In other embodiments, a system according to the invention does not include a programming device or other computing device. For example, an external medical device according to the invention may include a display, collect sleep quality and activity information as described herein, and display sleep quality and activity information to a user via the display.
  • In one embodiment, the invention is directed to a method in which a plurality of physiological parameters of a patient are monitored. The plurality of physiological parameters includes at least one physiological parameter indicative of patient physical activity. The method includes a determination of when the patient is attempting to sleep. Values of at least one metric that is indicative of sleep quality are determined based on at least one of the physiological parameters and a determination that the patient is attempting to sleep. An activity level of the patient is periodically determined based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep.
  • In another embodiment, the invention is directed to a medical system including a device and a processor. The device monitors a plurality of physiological parameters of a patient, and the plurality of physiological parameters includes at least one physiological parameter indicative of patient physical activity. The processor determines when the patient is attempting to sleep, determines values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep, and periodically determines an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep.
  • In another embodiment, the invention is directed to a medical system including means for monitoring a plurality of physiological parameters of a patient, wherein the plurality of physiological parameters includes at least one physiological parameter indicative of patient physical activity, means for determining when the patient is attempting to sleep, means for determining values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep, and means for periodically determining an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep.
  • In another embodiment, the invention is directed to a medical system including an implantable medical device and an external programming device that includes a display. The implantable medical device delivers a therapy to a patient based on a plurality of therapy parameter sets, monitors a plurality of physiological parameters, of the patient including at least one physiological parameter indicative of patient physical activity, determines when the patient is attempting to sleep, determines values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep, periodically determines an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep, associates each determined sleep quality metric value and each determined activity level with a current therapy parameter set, determines a representative value of each of the at least one sleep quality metrics for each of the plurality of therapy parameter sets based on the sleep quality metric values associated with the therapy parameter set, and determines at least one activity metric value for each of the plurality of therapy parameter sets based on the activity levels associated with the therapy parameter set. The external programming device receives information identifying the plurality of therapy parameter sets and the sleep quality metric values and activity metric values associated with the therapy parameter sets from the implantable medical device, and presents a list of the therapy parameter sets and the associated sleep quality metric values to a user.
  • In another embodiment, the invention is directed to a computer-readable medium comprising program instructions. The program instructions cause a programmable processor to monitor a plurality of physiological parameters of a patient, wherein the plurality of physiological parameters includes at least one physiological parameter indicative of patient physical activity, determine when the patient is attempting to sleep, determine values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep, and periodically determine an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep.
  • The invention may be capable of providing one or more advantages. For example, by providing information related to patient activity and the quality of a patient's sleep to a clinician and/or the patient, a system according to the invention can improve the course of treatment of an ailment of the patient, such as chronic pain. For example, using activity and sleep quality information provided by the system, the clinician could evaluate a plurality of therapy parameter sets to identify those which are, or are not, efficacious.
  • The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
  • BRIEF DESCRIPTION OF DRAWINGS
  • FIG. 1 is a conceptual diagram illustrating an example system that includes an implantable medical device that collects sleep quality information and activity information according to the invention.
  • FIG. 2 is a block diagram further illustrating the example system and implantable medical device of FIG. 1.
  • FIG. 3 is a block diagram illustrating an example memory of the implantable medical device of FIG. 1.
  • FIG. 4 is a flow diagram illustrating an example method for collecting sleep quality information and activity information that may be employed by an implantable medical device.
  • FIG. 5 is a flow diagram illustrating an example method for collecting sleep quality information that may be employed by an implantable medical device.
  • FIG. 6 is a flow diagram illustrating an example method for collecting activity information that may be employed by an implantable medical device.
  • FIG. 7 is a flow diagram illustrating an example method for associating sleep quality information and activity information with therapy parameter sets that may be employed by an implantable medical device.
  • FIG. 8 is a block diagram illustrating an example clinician programmer.
  • FIG. 9 illustrates an example list of therapy parameter sets and associated sleep quality information and activity information that may be presented by a clinician programmer.
  • FIG. 10 is a flow diagram illustrating an example method for displaying a list of therapy parameter sets and associated sleep quality information and activity information that may be employed by a clinician programmer.
  • FIG. 11 is a conceptual diagram illustrating a monitor that monitors values of one or more physiological parameters of the patient.
  • DETAILED DESCRIPTION
  • FIG. 1 is a conceptual diagram illustrating an example system 10 that includes an implantable medical device (IMD) 14 that collects information relating to the quality of sleep experienced by a patient 12 and the activity of patient 12 according to the invention. Sleep quality information and activity information collected by IMD 14 is provided to a user, such as a clinician or the patient. Using the sleep quality information and activity information collected by IMD 14, a current course of therapy for an ailment of patient 12 may be evaluated, and an improved course of therapy for the ailment may be identified.
  • In the illustrated example system 10, IMD 14 takes the form of an implantable neurostimulator that delivers neurostimulation therapy in the form of electrical pulses to patient 12. However, the invention is not limited to implementation via an implantable neurostimulator. For example, in some embodiments of the invention, an implantable pump or implantable cardiac rhythm management device, such as a pacemaker may collect sleep quality information and activity information. Further, the invention is not limited to implementation via an IMD. In other words, any implantable or external medical device may collect sleep quality and activity information according to the invention.
  • In the example of FIG. 1, IMD 14 delivers neurostimulation therapy to patient 12 via leads 16A and 16B (collectively “leads 16”). Leads 16 may, as shown in FIG. 1, be implanted proximate to the spinal cord 18 of patient 12, and IMD 14 may deliver spinal cord stimulation (SCS) therapy to patient 12 in order to, for example, reduce pain experienced by patient 12. However, the invention is not limited to the configuration of leads 16 shown in FIG. 1 or the delivery of SCS therapy. For example, one or more leads 16 may extend from IMD 14 to the brain (not shown) of patient 12, and IMD 14 may deliver deep brain stimulation (DBS) therapy to patient 12 to, for example, treat tremor or epilepsy. As further examples, one or more leads 16 may be implanted proximate to the pelvic nerves (not shown) or stomach (not shown), and IMD 14 may deliver neurostimulation therapy to treat incontinence, sexual dysfunction or gastroparesis.
  • IMD 14 delivers therapy according to a set of therapy parameters, i.e., a set of values for a number of parameters that define the therapy delivered according to that therapy parameter set. In embodiments where IMD 14 delivers neurostimulation therapy in the form of electrical pulses, the parameters for each therapy parameter set may include voltage or current pulse amplitudes, pulse widths, pulse rates, and the like. Further, each of leads 16 includes electrodes (not shown in FIG. 1), and a therapy parameter set may include information identifying which electrodes have been selected for delivery of pulses, and the polarities of the selected electrodes. Therapy parameter sets used by IMD 14 may include a number of parameter sets programmed by a clinician (not shown), and parameter sets representing adjustments made by patient 12 to these preprogrammed sets.
  • System 10 also includes a clinician programmer 20. A clinician (not shown) may use clinician programmer 20 to program therapy for patient 12, e.g., specify a number of therapy parameter sets and provide the parameter sets to IMD 14. The clinician may also use clinician programmer 20 to retrieve information collected by IMD 14. The clinician may use clinician programmer 20 to communicate with IMD 14 both during initial programming of IMD 14, and for collection of information and further programming during follow-up visits.
  • Clinician programmer 20 may, as shown in FIG. 1, be a handheld computing device. Clinician programmer 20 includes a display 22, such as a LCD or LED display, to display information to a user. Clinician programmer 20 may also include a keypad 24, which may be used by a user to interact with clinician programmer 20. In some embodiments, display 22 may be a touch screen display, and a user may interact with clinician programmer 20 via display 22. A user may also interact with clinician programmer 20 using peripheral pointing devices, such as a stylus or mouse. Keypad 24 may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions.
  • System 10 also includes a patient programmer 26, which also may, as shown in FIG. 1, be a handheld computing device. Patient 12 may use patient programmer 26 to control the delivery of therapy by IMD 14. For example, using patient programmer 26, patient 12 may select a current therapy parameter set from among the therapy parameter sets preprogrammed by the clinician, or may adjust one or more parameters of a preprogrammed therapy parameter set to arrive at the current therapy parameter set.
  • Patient programmer 26 may include a display 28 and a keypad 30, to allow patient 12 to interact with patient programmer 26. In some embodiments, display 28 may be a touch screen display, and patient 12 may interact with patient programmer 26 via display 28. Patient 12 may also interact with patient programmer 26 using peripheral pointing devices, such as a stylus, mouse, or the like.
  • However, clinician and patient programmers 20, 26 are not limited to the hand-held computer embodiments illustrated in FIG. 1. Programmers 20, 26 according to the invention may be any sort of computing device. For example, a programmer 20, 26 according to the invention may be a tablet-based computing device, a desktop computing device, or a workstation.
  • IMD 14, clinician programmer 20 and patient programmer 26 may, as shown in FIG. 1, communicate via wireless communication. Clinician programmer 20 and patient programmer 26 may, for example, communicate via wireless communication with IMD 14 using radio frequency (RF) or infrared telemetry techniques known in the art. Clinician programmer 20 and patient programmer 26 may communicate with each other using any of a variety of local wireless communication techniques, such as RF communication according to the 802.11 or Bluetooth specification sets, infrared communication according to the IRDA specification set, or other standard or proprietary telemetry protocols.
  • Clinician programmer 20 and patient programmer 26 need not communicate wirelessly, however. For example, programmers 20 and 26 may communicate via a wired connection, such as via a serial communication cable, or via exchange of removable media, such as magnetic or optical disks, or memory cards or sticks. Further, clinician programmer 20 may communicate with one or both of IMD 14 and patient programmer 26 via remote telemetry techniques known in the art, communicating via a local area network (LAN), wide area network (WAN), public switched telephone network (PSTN), or cellular telephone network, for example.
  • As mentioned above, IMD 14 collects information that relates to the quality of sleep experienced by patient 12 and the activity of patient 12. In particular, as will be described in greater detail below, IMD 14 determines whether patient 12 is attempting to sleep, determines values for one or more sleep quality metrics when patient 12 is attempting to sleep, and periodically determines activity levels of patient 12 when patient 12 is not attempting to sleep, i.e., is more likely to be active. In some embodiments, IMD 14 determines values for one or more activity metrics based on the determined activity levels. IMD 14 may include or be coupled to one or more sensors (not shown in FIG. 1), each of which generates a signal as a function of one or more of these physiological parameters, and may determine sleep quality metrics and activity levels based on the signals output by the sensors.
  • At any given time, as indicated above, IMD 14 delivers the therapy according to a current set of therapy parameters. Different therapy parameter sets may be selected, e.g., by patient 12 via patient programmer 26 or IMD 14 according to a schedule, and parameters of one or more therapy parameter sets may be adjusted by patient 12 via patient programmer 26 to create new therapy parameter sets. In other words, over time, IMD 14 delivers the therapy according to a plurality of therapy parameter sets.
  • In some embodiments, as will be described in greater detail below, IMD 14 identifies the therapy parameter set currently used to deliver therapy to patient 12 when a value of a sleep quality metric or an activity level is determined, and may associate the determined values and levels with current therapy parameter sets. For each of the plurality of therapy parameter sets, IMD 14 may store a representative value of each of one or more sleep quality metrics in a memory with an indication of the therapy parameter set with which that representative value is associated. A representative value of a sleep quality metric for a therapy parameter set may be the mean or median of collected sleep quality metric values that have been associated with that therapy parameter set. For each available therapy parameter set, IMD 14 may also store one or more associated activity metric values that are determined based on activity levels associated with that therapy parameter set.
  • A programming or other computing device, such as clinician programmer 20, may receive information identifying the therapy parameter set, representative sleep quality metric values associated with the plurality of therapy parameter sets, and activity metric values associated with the therapy parameter sets from IMD 14. Clinician programmer 20 may display a list of the therapy parameter sets, which may be ordered according to any of the associated representative sleep quality metric values or activity metric values. A clinician may select the metric by which the list is ordered. Such a list may be used by the clinician to, for example, identify effective or ineffective therapy parameter sets.
  • FIG. 2 is a block diagram further illustrating system 10. In particular, FIG. 2 illustrates an example configuration of IMD 14 and leads 16A and 16B. FIG. 2 also illustrates sensors 40A and 40B (collectively “sensors 40”) that generate signals as a function of one or more physiological parameters of patient 12. As will be described in greater detail below, IMD 14 monitors at least some of the signals to determine values for one or more metrics that are indicative of sleep quality when the patient is attempting to sleep, and monitors at least some of the signals to determine activity levels of patient 12 when the patient is not attempting to sleep.
  • IMD 14 may deliver neurostimulation therapy via electrodes 42A-D of lead 16A and electrodes 42E-H of lead 16B (collectively “electrodes 42”). Electrodes 42 may be ring electrodes. The configuration, type and number of electrodes 42 illustrated in FIG. 2 are merely exemplary. For example, leads 16A and 16B may each include eight electrodes 42, and the electrodes 42 need not be arranged linearly on each of leads 16A and 16B.
  • Electrodes 42 are electrically coupled to a therapy delivery module 44 via leads 16A and 16B. Therapy delivery module 44 may, for example, include an output pulse generator coupled to a power source such as a battery. Therapy delivery module 44 may deliver electrical pulses to patient 12 via at least some of electrodes 42 under the control of a processor 46, which controls therapy delivery module 44 to deliver neurostimulation therapy according to to a current therapy parameter set. However, the invention is not limited to implantable neurostimulator embodiments or even to IMDs that deliver electrical stimulation. For example, in some embodiments, a therapy delivery module 44 of an IMD may include a pump, circuitry to control the pump, and a reservoir to store a therapeutic agent for delivery via the pump.
  • Processor 46 may include a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or the like. Memory 48 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, and the like. In some embodiments, memory 48 stores program instructions that, when executed by processor 46, cause IMD 14 and processor 46 to perform the functions attributed to them herein.
  • Each of sensors 40 generates a signal as a function of one or more physiological parameters of patient 12. IMD 14 may include circuitry (not shown) that conditions the signals generated by sensors 40 such that they may be analyzed by processor 46. For example, IMD 14 may include one or more analog to digital converters to convert analog signals generated by sensors 40 into digital signals usable by processor 46, as well as suitable filter and amplifier circuitry. Although shown as including two sensors 40, system 10 may include any number of sensors.
  • Further, as illustrated in FIG. 2, sensors 40 may be included as part of IMD 14, or coupled to IMD 14 via leads 16. Sensors 40 may be coupled to IMD 14 via therapy leads 16A and 16B, or via other leads 16, such as lead 16C depicted in FIG. 2. In some embodiments, a sensor 40 located outside of IMD 14 may be in wireless communication with processor 46. Wireless communication between sensors 40 and IMD 14 may, as examples, include RF communication or communication via electrical signals conducted through the tissue and/or fluid of patient 12.
  • Exemplary physiological parameters of patient 12 that may be monitored by IMD 14 include activity, posture, heart rate, ECG morphology, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid (CSF), muscular activity and tone, core temperature, subcutaneous temperature, arterial blood flow, the level of melatonin within one or more bodily fluids, brain electrical activity, and eye motion. Further, as discussed above, in some external medical device embodiments of the invention, galvanic skin response may additionally or alternatively be monitored. Sensors 40 may be of any type known in the art capable of generating a signal as a function of one or more of these parameters.
  • Processor 46 may identify when patient 12 is attempting to sleep in a variety of ways. For example, processor 46 may identify the time that patient begins attempting to fall asleep based on an indication received from patient 12, e.g., via clinician programmer 20 and a telemetry circuit 50. In other embodiments, processor 46 identifies the time that patient 12 begins attempting to fall asleep based on the activity level of patient 12.
  • In such embodiments, IMD 14 may include one or more sensors 40 that generate a signal as a function of patient activity. For example, sensors 40 may include one or more accelerometers, gyros, mercury switches, or bonded piezoelectric crystals that generates a signal as a function of patient activity, e.g., body motion, footfalls or other impact events, and the like. Additionally or alternatively, sensors 40 may include one or more electrodes that generate an electromyogram (EMG) signal as a function of muscle electrical activity, which may indicate the activity level of a patient. The electrodes may be, for example, located in the legs, abdomen, chest, back or buttocks of patient 12 to detect muscle activity associated with walking, running, or the like. The electrodes may be coupled to IMD 14 wirelessly or by leads 16 or, if IMD 14 is implanted in these locations, integrated with a housing of IMD 14.
  • However, bonded piezoelectric crystals located in these areas generate signals as a function of muscle contraction in addition to body motion, footfalls or other impact events. Consequently, use of bonded piezoelectric crystals to detect activity of patient 12 may be preferred in some embodiments in which it is desired to detect muscle activity in addition to body motion, footfalls, or other impact events. Bonded piezoelectric crystals may be coupled to IMD 14 wirelessly or via leads 16, or piezoelectric crystals may be bonded to the can of IMD 14 when the IMD is implanted in these areas, e.g., in the back, chest, buttocks or abdomen of patient 12.
  • Processor 46 may identify a time when the activity level of patient 12 falls below a threshold activity level value stored in memory 48, and may determine whether the activity level remains substantially below the threshold activity level value for a threshold amount of time stored in memory 48. In other words, patient 12 remaining inactive for a sufficient period of time may indicate that patient 12 is attempting to fall asleep. If processor 46 determines that the threshold amount of time is exceeded, processor 46 may identify the time at which the activity level fell below the threshold activity level value as the time that patient 12 began attempting to fall asleep.
  • In some embodiments, processor 46 determines whether patient 12 is attempting to fall asleep based on whether patient 12 is or is not recumbent, e.g., lying down. In such embodiments, sensors 40 may include a plurality of accelerometers, gyros, or magnetometers oriented orthogonally that generate signals which indicate the posture of patient 12. In addition to being oriented orthogonally with respect to each other, each of sensors 40 used to detect the posture of patient 12 may be generally aligned with an axis of the body of patient 12. In exemplary embodiments, IMD 14 includes three orthogonally oriented posture sensors 40.
  • When sensors 40 include accelerometers, for example, that are aligned in this manner, processor 46 may monitor the magnitude and polarity of DC components of the signals generated by the accelerometers to determine the orientation of patient 12 relative to the Earth's gravity, e.g., the posture of patient 12. In particular, the processor 46 may compare the DC components of the signals to respective threshold values stored in memory 48 to determine whether patient 12 is or is not recumbent. Further information regarding use of orthogonally aligned accelerometers to determine patient posture may be found in a commonly assigned U.S. Pat. No. 5,593,431, which issued to Todd J. Sheldon.
  • Other sensors 40 that may generate a signal that indicates the posture of patient 12 include electrodes that generate an electromyogram (EMG) signal, or bonded piezoelectric crystals that generate a signal as a function of contraction of muscles. Such sensors 40 may be implanted in the legs, buttocks, abdomen, or back of patient 12, as described above. The signals generated by such sensors when implanted in these locations may vary based on the posture of patient 12, e.g., may vary based on whether the patient is standing, sitting, or laying down.
  • Further, the posture of patient 12 may affect the thoracic impedance of the patient. Consequently, sensors 40 may include an electrode pair, including one electrode integrated with the housing of IMD 14 and one of electrodes 42, that generates a signal as a function of the thoracic impedance of patient 12, and processor 46 may detect the posture or posture changes of patient 12 based on the signal. The electrodes of the pair may be located on opposite sides of the patient's thorax. For example, the electrode pair may include one of electrodes 42 located proximate to the spine of a patient for delivery of SCS therapy, and IMD 14 with an electrode integrated in its housing may be implanted in the abdomen of patient 12.
  • Additionally, changes of the posture of patient 12 may cause pressure changes with the cerebrospinal fluid (CSF) of the patient. Consequently, sensors 40 may include pressure sensors coupled to one or more intrathecal or intracerebroventricular catheters, or pressure sensors coupled to IMD 14 wirelessly or via lead 16. CSF pressure changes associated with posture changes may be particularly evident within the brain of the patient, e.g., may be particularly apparent in an intracranial pressure (ICP) waveform.
  • In some embodiments, processor 46 considers both the posture and the activity level of patient 12 when determining whether patient 12 is attempting to fall asleep. For example, processor 46 may determine whether patient 12 is attempting to fall asleep based on a sufficiently long period of sub-threshold activity, as described above, and may identify the time that patient began attempting to fall asleep as the time when patient 12 became recumbent. Any of a variety of combinations or variations of these techniques may be used to determine when patient 12 is attempting to fall asleep, and a specific one or more techniques may be selected based on the sleeping and activity habits of a particular patient.
  • In other embodiments, processor 46 determines when patient 12 is attempting to fall asleep based on the level of melatonin in a bodily fluid. In such embodiments, a sensor 40 may take the form of a chemical sensor that is sensitive to the level of melatonin or a metabolite of melatonin in the bodily fluid, and estimate the time that patient 12 will attempt to fall asleep based on the detection. For example, processor 46 may compare the melatonin level or rate of change in the melatonin level to a threshold level stored in memory 48, and identify the time that threshold value is exceeded. Processor 46 may identify the time that patient 12 is attempting to fall asleep as the time that the threshold is exceeded, or some amount of time after the threshold is exceeded. Any of a variety of combinations or variations of the above-described techniques may be used to determine when patient 12 is attempting to fall asleep, and a specific one or more techniques may be selected based on the sleeping and activity habits of a particular patient.
  • When IMD 14 determines that patient 12 is attempting to sleep, IMD 14 may determine values for one or more metrics that indicate the quality of a patient's sleep based on at least one of the above-identified physiological parameters of the patient. In particular, in order to determine values for some sleep quality metrics, IMD 14 determines when patient 12 is asleep, e.g., identify the times that patient 12 falls asleep and wakes up, in addition to when patient 12 is attempting to fall asleep. The detected values of physiological parameters of patient 12, such as activity level, heart rate, ECG morphological features, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity and tone, core temperature, subcutaneous temperature, arterial blood flow, brain electrical activity, eye motion, and galvanic skin response may discernibly change when patient 12 falls asleep or awakes. Some of these physiological parameters may be at low values when patient 12 is asleep. Further, the variability of at least some of these parameters, such as heart rate and respiration rate, may be at a low value when the patient is asleep.
  • Consequently, in order to detect when patient 12 falls asleep and wakes up, processor 46 may monitor one or more of these physiological parameters, or the variability of these physiological parameters, and detect the discemable changes in their values associated with a transition between a sleeping state and an awake state. In some embodiments, processor 46 may determine a mean or median value for a parameter based on values of a signal over time, and determine whether patient 12 is asleep or awake based on the mean or median value. Processor 46 may compare one or more parameter or parameter variability values to thresholds stored in memory 48 to detect when patient 12 falls asleep or awakes. The thresholds may be absolute values of a physiological parameter, or time rate of change values for the physiological parameter, e.g., to detect sudden changes in the value of a parameter or parameter variability. In some embodiments, a threshold used by processor 46 to determine whether patient 12 is asleep may include a time component. For example, a threshold may require that a physiological parameter be above or below a threshold value for a period of time before processor 46 determines that patient is awake or asleep.
  • In some embodiments, in order to determine whether patient 12 is asleep, processor 46 monitors a plurality of physiological parameters, and determines a value of a metric that indicates the probability that patient 12 is asleep for each of the parameters based on a value of the parameter. In particular, the processor 46 may apply a function or look-up table to the current, mean or median value, and/or the variability of each of a plurality of physiological parameters to determine a sleep probability metric for each of the plurality of physiological parameters. A sleep probability metric value may be a numeric value, and in some embodiments may be a probability value, e.g., a number within the range from 0 to 1, or a percentage value.
  • Processor 46 may average or otherwise combine the plurality of sleep probability metric values to provide an overall sleep probability metric value. In some embodiments, processor 46 may apply a weighting factor to one or more of the sleep probability metric values prior to combination. Processor 46 may compare the overall sleep probability metric value to one or more threshold values stored in memory 48 to determine when patient 12 falls asleep or awakes. Use of sleep probability metric values to determine when a patient is asleep based on a plurality of monitored physiological parameters is described in greater detail in a commonly-assigned and copending U.S. patent application Ser. No. __________ by Ken Heruth and Keith Miesel, entitled “DETECTING SLEEP,” bearing Attorney Docket No. 1023-360US02 and filed on Mar. 16, 2005, which is incorporated herein by reference in its entirety.
  • To enable processor 46 to determine when patient 12 is asleep or awake, sensors 40 may include, for example, activity sensors as described above. In some embodiments, the activity sensors may include electrodes or bonded piezoelectric crystals, which may be implanted in the back, chest, buttocks, or abdomen of patient 12 as described above. In such embodiments, processor 46 may detect the electrical activation and contractions of muscles associated with gross motor activity of the patient, e.g., walking,.running or the like via the signals generated by such sensors. Processor 46 may also detect spasmodic or pain related muscle activation via the signals generated by such sensors. Spasmodic or pain related muscle activation may indicate that patient 12 is not sleeping, e.g., unable to sleep, or if patient 12 is sleeping, may indicate a lower level of sleep quality.
  • As another example, sensors 40 may include electrodes located on leads or integrated as part of the housing of IMD 14 that generate an electrogram signal as a function of electrical activity of the heart of patient 12, and processor 46 may monitor the heart rate of patient 12 based on the electrogram signal. In other embodiments, a sensor may include an acoustic sensor within IMD 14, a pressure or flow sensor within the bloodstream or cerebrospinal fluid of patient 12, or a temperature sensor located within the bloodstream of patient 12. The signals generated by such sensors may vary as a function of contraction of the heart of patient 12, and can be used by IMD 14 to monitor the heart rate of patient 12.
  • In some embodiments, processor 46 may detect, and measure values for one or more ECG morphological features within an electrogram generated by electrodes as described above. ECG morphological features may vary in a manner that indicates whether patient 12 is asleep or awake. For example, the amplitude of the ST segment of the ECG may decrease when patient 12 is asleep. Further, the amplitude of QRS complex or T-wave may decrease, and the widths of the QRS complex and T-wave may increase when patient 12 is asleep. The QT interval and the latency of an evoked response may increase when patient 12 is asleep, and the amplitude of the evoked response may decrease when patient 12 is asleep.
  • In some embodiments, sensors 40 may include an electrode pair, including one electrode integrated with the housing of IMD 14 and one of electrodes 42, that generates a signal as a function of the thoracic impedance of patient 12, as described above, which varies as a function of respiration by patient 12. In other embodiments, sensors 40 may include a strain gauge, bonded piezoelectric element, or pressure sensor within the blood or cerebrospinal fluid that generates a signal that varies based on patient respiration. An electrogram generated by electrodes as discussed above may also be modulated by patient respiration, and may be used as an indirect representation of respiration rate.
  • Sensors 40 may include electrodes that generate an electromyogram (EMG) signal as a function of muscle electrical activity, as described above, or may include any of a variety of known temperature sensors to generate a signal as a function of a core or subcutaneous temperature of patient 12. Such electrodes and temperature sensors may be incorporated within the housing of IMD 14, or coupled to IMD 14 wirelessly or via leads. Sensors 40 may also include a pressure sensor within, or in contact with, a blood vessel. The pressure sensor may generate a signal as a function of the a blood pressure of patient 12, and may, for example, comprise a Chronicle Hemodynamic Monitor™ commercially available from Medtronic, Inc. of Minneapolis, Minnesota. Further, certain muscles of patient 12, such as the muscles of the patient's neck, may discernibly relax when patient 12 is asleep or within certain sleep states. Consequently, sensors 40 may include strain gauges or EMG electrodes implanted in such locations that generate a signal as a function of muscle tone.
  • Sensors 40 may also include optical pulse oximetry sensors or Clark dissolved oxygen sensors located within, as part of a housing of, or outside of IMD 14, which generate signals as a function of blood oxygen saturation and blood oxygen partial pressure respectively. In some embodiments, system 10 may include a catheter with a distal portion located within the cerebrospinal fluid of patient 12, and the distal end may include a Clark dissolved oxygen sensor to generate a signal as a function of the partial pressure of oxygen within the cerebrospinal fluid (CSF). Embodiments in which an IMD comprises an implantable pump, for example, may include a catheter with a distal portion located in the cerebrospinal fluid.
  • In some embodiments, sensors 40 may include one or more intraluminal, extraluminal, or external flow sensors positioned to generate a signal as a function of arterial blood flow. A flow sensor may be, for example, an electromagnetic, thermal convection, ultrasonic-Doppler, or laser-Doppler flow sensor. Further, in some external medical device embodiments of the invention, sensors 40 may include one or more electrodes positioned on the skin of patient 12 to generate a signal as a function of galvanic skin response.
  • Additionally, in some embodiments, sensors 40 may include one or more electrodes positioned within or proximate to the brain of patient, which detect electrical activity of the brain. For example, in embodiments in which IMD 14 delivers stimulation or other therapy to the brain, processor 46 may be coupled to electrodes implanted on or within the brain via a lead 16. In other embodiments, processor 46 may be wirelessly coupled to electrodes that detect brain electrical activity.
  • For example, one or more modules may be implanted beneath the scalp of the patient, each module including a housing, one or more electrodes, and circuitry to wirelessly transmit the signals detected by the one or more electrodes to IMD 14. In other embodiments, the electrodes may be applied to the patient's scalp, and electrically coupled to a module that includes circuitry for wirelessly transmitting the signals detected by the electrodes to IMD 14. The electrodes may be glued to the patient's scalp, or a head band, hair net, cap, or the like may incorporate the electrodes and the module, and may be worn by patient 12 to apply the electrodes to the patient's scalp when, for example, the patient is attempting to sleep. The signals detected by the electrodes and transmitted to IMD 14 may be electroencephalogram (EEG) signals, and processor 46 may process the EEG signals to detect when patient 12 is asleep using any of a variety of known techniques, such as techniques that identify whether a patient is asleep based on the amplitude and/or frequency of the EEG signals.
  • Also, the motion of the eyes of patient 12 may vary depending on whether the patient is sleeping and which sleep state the patient is in. Consequently, sensors 40 may include electrodes place proximate to the eyes of patient 12 to detect electrical activity associated with motion of the eyes, e.g., to generate an electro-oculography (EOG) signal. Such electrodes may be coupled to IMD 14 via one or more leads 16, or may be included within modules that include circuitry to wirelessly transmit detected signals to IMD 14. Wirelessly coupled modules incorporating electrodes to detect eye motion may be worn externally by patient 12, e.g., attached to the skin of patient 12 proximate to the eyes by an adhesive when the patient is attempting to sleep.
  • Processor 46 may also detect arousals and/or apneas that occur when patient 12 is asleep based on one or more of the above-identified physiological parameters. For example, processor 46 may detect an arousal based on an increase or sudden increase in one or more of heart rate, heart rate variability, respiration rate, respiration rate variability, blood pressure, or muscular activity as the occurrence of an arousal. Processor 46 may detect an apnea based on a disturbance in the respiration rate of patient 12, e.g., a period with no respiration.
  • Processor 46 may also detect arousals or apneas based on sudden changes in one or more of the ECG morphological features identified above. For example, a sudden elevation of the ST segment within the ECG may indicate an arousal or an apnea. Further, sudden changes in the amplitude or frequency of an EEG signal, EOG signal, or muscle tone signal may indicate an apnea or arousal. Memory 48 may store thresholds used by processor 46 to detect arousals and apneas. Processor 46 may determine, as a sleep quality metric value, the number of apnea events and/or arousals during a night.
  • Further, in some embodiments, processor 46 may determine which sleep state patient 12 is in during sleep, e.g., REM, S1, S2, S3, or S4, based on one or more of the monitored physiological parameters. In some embodiments, memory 48 may store one or more thresholds for each of sleep states, and processor 46 may compare physiological parameter or sleep probability metric values to the thresholds to determine which sleep state patient 12 is currently in. Further, in some embodiments, processor 46 may use any of a variety of known techniques for determining which sleep state patient is in based on an EEG signal, which processor 46 may receive via electrodes as described above, such as techniques that identify sleep state based on the amplitude and/or frequency of the EEG signals. In some embodiments, processor 46 may also determine which sleep state patient is in based on an EOG signal, which processor 46 may receive via electrodes as described above, either alone or in combination with an EEG signal, using any of a variety of techniques known in the art. Processor 46 may determine, as sleep quality metric values, the amounts of time per night spent in the various sleep states.
  • The S3 and S4 sleep states may be of particular importance to the quality of sleep experienced by patient 12. Interruption from reaching these states, or inadequate time per night spent in these states, may cause patient 12 to not feel rested. For this reason, the S3 and S4 sleep states are believed to provide the “refreshing” part of sleep.
  • In some cases, interruption from reaching the S3 and S4 sleep states, or inadequate time per night spent in these states has been demonstrated to cause normal subjects to exhibit some symptoms of fibromyalgia. Also, subjects with fibromyalgia usually do not reach these sleep states. For these reasons, in some embodiments, IMD 14 may determine an amount or percentage of time spent in one or both of the S3 and S4 sleep states as a sleep quality metric.
  • When processor 46 determines that patient 12 is not attempting to sleep, processor 46 periodically determines activity levels of the patient. For example, a sensor 40 may be an accelerometer, a bonded piezoelectric crystal, a mercury switch, or a gyro, and processor 46 may determine an activity level based on a signal generated by one of these types of sensors 40 by sampling the signal and determining a number of activity counts during the sample period. Processor 46 may then store the determined number of activity counts in memory 48 as an activity level.
  • For example, processor 46 may compare the sample of a signal generated by an accelerometer or piezoelectric crystal to one or more amplitude thresholds stored within memory 48. Processor 46 may identify each threshold crossing as an activity count. Where processor 46 compares the sample to multiple thresholds with varying amplitudes, processor 46 may identify crossing of higher amplitude thresholds as multiple activity counts. Using multiple thresholds to identify activity counts, processor 46 may be able to more accurately determine the extent of patient activity for both high impact, low frequency and low impact, high frequency activities. In embodiments in which a sensor 40 takes the form of a mercury switch, processor 46 may identify the number of switch contacts indicated during the sample period as the number of activity counts.
  • In embodiments in which a sensor 40 comprises an accelerometer or piezoelectric crystal, IMD 14 may include a filter (not shown), or processor 46 may apply a digital filter, that passes a band from approximately 0.1 Hz to 10 Hz. The filter may reduce noise in the signal, and pass the portion of the signal that reflects patient activity.
  • In some embodiments, the processor 46 may monitor a signal that indicates a physiological parameter of patient 12, which in turn varies as a function of patient activity. For example, in some embodiments, sensors 40 may includes one or more sensors that generate a signal that indicates the heart rate, ECG morphology, respiration rate, respiratory volume, or muscular activity of the patient, as described above. In such embodiments, processor 46 may periodically determine the heart rate, values of ECG morphological features, respiration rate, respiratory volume, or muscular activity level of patient 12 based on the signal. The determined values of these parameters may be mean or median values.
  • In some embodiments, processor 46 compares a determined value of such a physiological parameter to one or more thresholds or a look-up table stored in memory to determine a number of activity counts, and stores the determined number of activity counts in memory 48 as a determined activity level. In other embodiments, processor 46 may store the determined physiological parameter value as a determined activity level. The use of activity counts, however, may allow processor 46 to determine an activity level based on a plurality of signals generated by a plurality of sensors 40. For example, processor 46 may determine a first number of activity counts based on a sample of an accelerometer signal and a second number of activity counts based on a heart rate determined from an electrogram signal at the time the accelerometer signal was sampled. Processor 46 may determine an activity level by calculating the sum or average, which may be a weighted sum or average, of first and second activity counts.
  • Processor 46 may record activity levels continuously or periodically, e.g., one sample every minute or continuously for ten minutes each hour. Further processor 46 need not determine sleep quality metrics each time patient 12 attempts to sleep, or record activity levels each time patient 12 is not attempting to sleep. In some embodiments, processor 46 may record activity levels and determine sleep quality metric values in response to receiving an indication from patient 12 via patient programmer 26. Patient 12 may provide the indication by depressing a button or otherwise manipulating user input media on programmer 26. For example, processor 46 may record activity levels and sleep quality metrics during times when patient 12 believes the therapy delivered by IMD 14 is ineffective and/or the symptoms experienced by patient 12 have worsened. In this manner, processor 46 may limit data collection to periods in which more probative data is likely to be collected, and thereby conserve a battery and/or storage space within memory 48.
  • In some embodiments, processor 46 determines a value of one or more activity metrics based on determined activity levels and stores the activity metric values within memory 48. For example, processor 46 may determine a mean or median of activity levels, and store the mean or median activity level as an activity metric value. In embodiments in which activity levels comprise activity counts, processor 46 may store, for example, an average number of activity counts per unit time as an activity metric value.
  • In other embodiments, processor 46 may compare a mean or median activity level to one or more threshold values, and may select an activity metric value from a predetermined scale of activity metric values based on the comparison. The scale may be numeric, such as activity metric values from 1-10, or qualitative, such as low, medium or high activity. The scale of activity metric values may be, for example, stored as a look-up table within memory 48. Processor 46 stores the activity metric value selected from the scale within memory 48.
  • In some embodiments, processor 46 compares a number of activity levels to one or more threshold values. Based on the comparison, processor 46 may determine percentages of time above and/or below the thresholds, or within threshold ranges. Processor 46 may store the determined percentages within memory 48 as one or more activity metric values. In other embodiments, processor 46 compares a number of activity levels to a threshold value, and determines an average length of time that consecutively recorded activity levels remained above the threshold as an activity metric value.
  • FIG. 3 further illustrates memory 48 of IMD 14. As illustrated in FIG. 3, memory 48 stores information describing a plurality of therapy parameter sets 60. Therapy parameter sets 60 may include parameter sets specified by a clinician using clinician programmer 20. Therapy parameter sets 60 may also include parameter sets that are the result of patient 12 changing one or more parameters of one of the preprogrammed therapy parameter sets.
  • Memory 48 also stores the activity levels 62, sleep quality metric values 66, and activity metric values 68 determined by processor 46, as described herein, and threshold values 64 used by processor 46 to determine activity levels 62, sleep quality metric values 66, and activity metric values 68, as described herein. In some embodiments, memory 48 also stores one or more functions or look-up tables (not shown) used by processor 46 to determine sleep probability metric values, activity levels 62, sleep quality metric values 66, and activity metric values 68, as described herein.
  • Processor 46 may store each sleep quality metric value determined within memory 48 as a sleep quality metric value 66, or may store mean or median sleep quality metric values over periods of time such as days, weeks or months as sleep quality metric values 66. Further, processor 46 may apply a function or look-up table to a plurality of sleep quality metric values to determine overall sleep quality metric value, and may store the overall sleep quality metric values within memory 48. The application of a function or look-up table by processor 46 for this purpose may involve the use or weighting factors for one or more of the individual sleep quality metric values.
  • Similarly, in some embodiments, processor 46 determines a plurality of activity metric values, and determines an overall activity metric value for a parameter set based on the values of the individual activity metrics for that parameter set. For example, processor 46 may use the plurality of individual activity metric values as indices to identify an overall activity metric value from a look-up table stored in memory 48. Processor 46 may select the overall metric value from a predetermined scale of activity metric values, which may be numeric, such as activity metric values from 1-10, or qualitative, such as low, medium or high activity.
  • In some embodiments, processor 46 identifies which of therapy parameter sets 60 is currently selected for use in delivering therapy to patient 12 when an activity level 62 or sleep quality metric value 66 is collected, and may associate that value or level with the current therapy parameter set. For example, for each of the plurality of therapy parameter sets 60, processor 46 may store a representative value of each of one or more sleep quality metrics within memory 48 as a sleep quality metric value 66 with an indication of the therapy parameter set with which that representative value is associated. A representative value of sleep quality metric for a therapy parameter set may be the mean or median of collected sleep quality metric values that have been associated with that therapy parameter set. Further, processor 46 may determine a value of one or more activity metrics for each of therapy parameter sets 60 based on activity levels 62 associated with that therapy parameter set, and may store the associated activity metric values 68 within memory 48.
  • As shown in FIG. 2, IMD 14 also includes a telemetry circuit 50 that allows processor 46 to communicate with clinician programmer 20 and patient programmer 26. Processor 46 may receive information identifying therapy parameter sets 60 preprogrammed by the clinician and threshold values 64 from clinician programmer 20 via telemetry circuit 50 for storage in memory 48. Processor 46 may receive an indication of the therapy parameter set 60 selected by patient 12 for delivery of therapy, or adjustments to one or more of therapy parameter sets 60 made by patient 12, from patient programmer 26 via telemetry circuit 50. Programmers 20, 26 may receive sleep quality metric values 66 and activity metric values 68 from processor 46 via telemetry circuit 50.
  • FIG. 4 is a flow diagram illustrating an example method for collecting sleep quality information and activity information that may be employed by IMD 14. IMD 14 monitors the posture, activity level, and/or melatonin level of patient 12, or monitors for an indication from patient 12, e.g., via patient programmer 26 (70), and determines whether patient 12 is attempting to fall asleep based on the posture, activity level, and/or a patient indication, as described above (72). When IMD 14 determines that patient 12 is not attempting to fall asleep, IMD 14 collects activity information, e.g., periodically determines activity levels 62 (74). When IMD 14 determines that patient 12 is attempting to fall asleep, IMD 14 collects sleep quality information, e.g., determines sleep quality metric values, until patient 12 is determined to be awake (76).
  • As discussed above, IMD 14 need not collect sleep information each time patient 12 attempts to sleep, or record activity levels each time patient 12 is not attempting to sleep. In some embodiments, IMD 14 may record activity levels and determine sleep quality metric values in response to receiving an indication from patient 12 via patient programmer 26. For example, IMD 14 may record activity levels and sleep quality metrics during times when patient 12 believes the therapy delivered by IMD 14 is ineffective and/or the symptoms experienced by patient 12 have worsened. In this manner, IMD 14 may limit data collection to periods in which more probative data is likely to be collected, and thereby conserve a battery and/or storage space within memory 48.
  • FIG. 5 is a flow diagram illustrating an example method for collecting sleep quality information that may be employed by IMD 14. When IMD 14 determines that patient 12 is attempting to fall asleep (FIG. 4), IMD 14 identifies the time that patient 12 began attempting to fall asleep using any of the techniques described above (80), and monitors one or more of the various physiological parameters of patient 12 discussed above to determine whether patient 12 is asleep (82, 84).
  • In some embodiments, IMD 14 compares parameter values or parameter variability values to one or more threshold values 64 to determine whether patient 12 is asleep. In other embodiments, IMD 14 applies one or more functions or look-up tables to determine one or more sleep probability metric values based on the physiological parameter values, and compares the sleep probability metric values to one or more threshold values 64 to determine whether patient 12 is asleep. While monitoring physiological parameters (82) to determine whether patient 12 is asleep (84), IMD 14 may continue to monitor the posture and/or activity level of patient 12 to confirm that patient 12 is still attempting to fall asleep.
  • When IMD 14 determines that patient 12 is asleep, e.g., by analysis of the various parameters contemplated herein, IMD 14 will identify the time that patient 12 fell asleep (86). While patient 12 is sleeping, IMD 14 will continue to monitor physiological parameters of patient 12 (88). As discussed above, IMD 14 may identify the occurrence of arousals and/or apneas based on the monitored physiological parameters (90). Further, IMD 14 may identify the time that transitions between sleep states, e.g., REM, S1, S2, S3, and S4, occur based on the monitored physiological parameters (90).
  • Additionally, while patient 12 is sleeping, IMD 14 monitors physiological parameters of patient 12 (88) to determine whether patient 12 has woken up (92). When IMD 14 determines that patient 12 is awake, IMD 14 identifies the time that patient 12 awoke (94), and determines sleep quality metric values based on the information collected while patient 12 was asleep (96).
  • For example, one sleep quality metric value IMD 14 may calculate is sleep efficiency, which IMD 14 may calculate as a percentage of time during which patient 12 is attempting to sleep that patient 12 is actually asleep. IMD 14 may determine a first amount of time between the time IMD 14 identified that patient 12 fell asleep and the time IMD 14 identified that patient 12 awoke. IMD may also determine a second amount of time between the time IMD 14 identified that patient 12 began attempting to fall asleep and the time IMD 14 identified that patient 12 awoke. To calculate the sleep efficiency, IMD 14 may divide the first time by the second time.
  • Another sleep quality metric value that IMD 14 may calculate is sleep latency, which IMD 14 may calculate as the amount of time between the time IMD 14 identified that patient 12 was attempting to fall asleep and the time IMD 14 identified that patient 12 fell asleep. Other sleep quality metrics with values determined by IMD 14 based on the information collected by IMD 14 in the illustrated example include: total time sleeping per day, at night, and during daytime hours; number of apnea and arousal events per occurrence of sleep; and amount of time spent in the various sleep states, e.g., the S3 and S4 sleep states. IMD 14 may store the determined values as sleep quality metric values 66 within memory 48.
  • FIG. 6 is a flow diagram illustrating an example method for collecting activity information that may be employed by IMD 14. IMD 14 monitors one or more signals that reflect patient activity generated by sensors 40 (100). For example, IMD 14 may monitor a signal generated by an accelerometer or piezoelectric crystal, and/or a signal that indicates a physiological parameter that varies as a function of patient activity, such as heart rate, ECG morphology, respiration rate, respiratory volume, or muscle activity.
  • IMD 14 determines an activity level 62 (102) based on the one or more signals. For example, IMD 14 may determine a number of activity counts based on the one or more signals, as described above. IMD 14 may then update one or more activity metric values 66 based on the determined activity level (104).
  • IMD 14 may periodically perform the method illustrated in FIG. 6, i.e., periodically determine activity levels 62. IMD 14 need not update activity metric values 66 each time an activity level 62 is determined. In some embodiments, for example, IMD 14 may store activity levels 62 within memory, and may determine the activity metric values 66 upon receiving a request for the values from clinician programmer 20.
  • FIG. 7 is a flow diagram illustrating an example method for associating sleep quality information and activity information with therapy parameter sets that may be employed by IMD 14. IMD 14 determines a value 66 of a sleep quality metric or an activity level 62 according to any of the techniques described above (110). IMD 14 also identifies the current therapy parameter set 60, e.g., the therapy parameter set 60 used by IMD 14 to control delivery of therapy when patient 12 was asleep or when the activity level was determined (112), and associates the newly determined level or value with the current therapy parameter set 60.
  • Among sleep quality metric values 66 within memory 48, IMD 14 stores a representative value of the sleep quality metric, e.g., a mean or median value, for each of the plurality of therapy parameter sets 60. When IMD 14 determines a new sleep quality metric value, IMD 14 updates the representative values for the current therapy parameter set based on the newly determined sleep quality metric value (114). For example, a newly determined sleep efficiency value may be used to determine a new average sleep efficiency value for the current therapy parameter set 60. Similarly, among the activity metric values 68 within memory 48, IMD 14 stores an associated activity metric value. When IMD 14 determines a new activity level 62, IMD 14 updates the activity metric value 68 the current therapy parameter set based on the newly determined activity level.
  • FIG. 8 is a block diagram further illustrating clinician programmer 20. A clinician may interact with a processor 120 via a user interface 122 in order to program therapy for patient 12, e.g., specify therapy parameter sets. Processor 120 may provide the specified therapy parameter sets to IMD 14 via telemetry circuit 124.
  • At another time, e.g., during a follow up visit, processor 120 may receive activity levels 62, sleep quality metric values 66, and/or activity metric values 68 from IMD 14 via a telemetry circuit 124, and may generate sleep quality information or activity information for presentation to the clinician via user interface 122. For example, processor 120 may present a trend diagram of activity levels 62 or sleep quality metric values 66 over time, or a histogram, pie chart, or other illustration of percentages of time that activity levels 62 or sleep quality metric values 66 were within certain ranges. Processor 120 may generate such charts or diagrams using activity levels 62 and sleep quality metric values 66 associated with a particular one of the therapy parameter sets 60, or all of the activity levels 62 and sleep quality metric values 66 recorded by IMD 14.
  • Processor 120 may also receive information identifying a plurality of therapy parameter sets 60, and representative sleep quality metric values 66 and activity metric values associated with the therapy parameter sets 60, from IMD 14 via telemetry circuit 124. The therapy parameter sets 60 may include the originally specified parameter sets, and parameter sets resulting from manipulation of one or more therapy parameters by patient 12 using patient programmer 26. After receiving this information, processor 120 generates a list of the therapy parameter sets 60 and associated sleep quality metric values 66 and activity metric values 68, and presents the list to the clinician via user interface 122.
  • User interface 112 may include display 22 and keypad 24, and may also include a touch screen or peripheral pointing devices as described above. Processor 110 may include a microprocessor, a controller, a DSP, an ASIC, an FPGA, discrete logic circuitry, or the like. Clinician programmer 20 also includes a memory 116. Memory 116 may include program instructions that, when executed by processor 110, cause clinician programmer 20 to perform the functions ascribed to clinician programmer 20 herein. Memory 116 may include any volatile, non-volatile, fixed, removable, magnetic, optical, or electrical media, such as a RAM, ROM, CD-ROM, hard disk, removable magnetic disk, memory cards or sticks, NVRAM, EEPROM, flash memory, and the like.
  • FIG. 9 illustrates an example list 130 of therapy parameter sets 60, associated sleep quality metric values 66, and associated activity metric values 68 that may be presented to a clinician by clinician programmer 20. Each row of example list 130 includes an identification of one of therapy parameter sets 60, the parameters of the set, a representative value for one or more sleep quality metrics associated with the identified therapy parameter set, and an associated value of at least one activity metric.
  • List 130 may include values for any number of sleep quality metrics and activity metrics. The illustrated example list 130 includes sleep efficiency, sleep latency and a percentage of time active. IMD 14 may determine the percentage of time active for one of parameter sets 60 by, for example, comparing each activity level 62 associated with the parameter set to an “active” threshold, i.e., a threshold indicative of significant physical activity, and determining the percentage of activity levels 62 above the threshold. As illustrated in FIG. 9, IMD 14 may also compare each activity level for the therapy parameter set to an additional, “high activity” threshold, and determine a percentage of activity levels 62 above that threshold.
  • FIG. 10 is a flow diagram illustrating an example method for displaying a list 130 of therapy parameter sets and associated sleep quality and activity information that may be employed by clinician programmer 20. According to the example method, clinician programmer 20 receives information identifying the plurality of therapy parameter sets 60 stored in memory 48 of IMD 14, one or more representative sleep quality metric values associated with each of the therapy parameter sets, and one or more activity metric values associated with each of the activity sets (140). Clinician programmer 20 generates a list 130 of the therapy parameter sets 60, any associated representative sleep quality metric values, and any associated activity metric values (142), and orders the list according to a selected one of the sleep quality metrics or activity metrics (144). For example, in the example list 130 illustrated in FIG. 9, the clinician may select whether list 130 should be ordered according to sleep efficiency, sleep latency, or percentage of time active via user interface 122 of clinician programmer 20.
  • Various embodiments of the invention have been described. However, one skilled in the art will recognize that various modifications may be made to the described embodiments without departing from the scope of the invention. For example, a patient programming device, such as patient programmer 26, may additionally or alternatively receive sleep quality metric values and/or activity metric values from IMD 14, and may provide sleep quality or activity information to a user based on the sleep quality or activity metric values. Further details regarding provision of sleep quality information to a patient via a patient programming device may be found in a commonly-assigned and copending U.S. patent application Ser. No. _______ by Ken Heruth and Keith Miesel, entitled “COLLECTING SLEEP QUALITY INFORMATION VIA A MEDICAL DEVICE,” bearing Attorney Docket No. 1023-350US02 and filed on Mar. 16, 2005, which is incorporated herein by reference in its entirety.
  • As another example, although described herein primarily in the context of treatment of pain with an implantable neurostimulator, the invention is not so limited. The invention may be embodied in any implantable medical device, such as a cardiac pacemaker, an implantable pump, or an implantable monitor that does not itself deliver a therapy to the patient. Further, the invention may be implemented via an external, e.g., non-implantable, medical device.
  • Additionally, the invention is not limited to embodiments in which a programming device receives information from the medical device, or presents information to a user. Other computing devices, such as handheld computers, desktop computers, workstations, or servers may receive information from the medical device and present information to a user as described herein with reference to programmers 20, 26. A computing device, such as a server, may receive information from the medical device and present information to a user via a network, such as a local area network (LAN), wide area network (WAN), or the Internet. Further, in some embodiments, the medical device is an external medical device, and may itself include user interface and display to present activity information to a user, such as a clinician or patient, for evaluation of therapy parameter sets.
  • As another example, the invention may be embodied in a trial neurostimulator, which is coupled to percutaneous leads implanted within the patient to determine whether the patient is a candidate for neurostimulation, and to evaluate prospective neurostimulation therapy parameter sets. Similarly, the invention may be embodied in a trial drug pump, which is coupled to a percutaneous catheter implanted within the patient to determine whether the patient is a candidate for an implantable pump, and to evaluate prospective therapeutic agent delivery parameter sets. Sleep quality metric values and activity metric values collected during use of the trial neurostimulator or pump may be used by a clinician to evaluate the prospective therapy parameter sets, and select parameter sets for use by the later implanted non-trial neurostimulator or pump. For example, a trial neurostimulator or pump may determine representative values of one or more sleep quality metrics and activity metric values for each of a plurality of prospective therapy parameter sets, and a clinician programmer may present a list of prospective parameter sets and associated representative values to a clinician. The clinician may use the list to identify potentially efficacious parameter sets, and may program a permanent implantable neurostimulator or pump for the patient with the identified parameter sets.
  • In some embodiments, a therapy delivering implantable or external medical device does not determine whether the patient is attempting to sleep, determine values for sleep quality metrics, determine activity metric values, and/or periodically determine activity levels. Instead, in some embodiments, a computing device, such as one of programming devices 20, 26, or the other types of computing devices identified above, performs one or more of these functions. For example, a programming device, and more particularly a processor of the programming device, e.g., processor 120, may receive physiological parameter values, activity levels, and/or samples of an activity signal from a medical device, and determine activity metric values and sleep quality metric values based on the information received from the medical device using any of the techniques described herein with reference to a medical device.
  • In some embodiments, the medical device may associate recorded physiological parameter values, signal samples, and/or activity levels with a current therapy parameter set, and may provide information identifying and plurality of therapy parameter sets and collected information associated with the therapy parameter sets to the programming device or other computing device. In such embodiments, the programming device may determine representative sleep quality metric values and activity metric values associated with the various therapy parameter sets using any of techniques described herein with reference to a medical device. The programming device may receive such information from the medical device in real time, or may interrogate the medical device for information recorded by the medical device over a period of time.
  • Additionally, the invention is not limited to embodiments in which the therapy delivering medical device monitors the physiological parameters of the patient described herein. In some embodiments, a separate monitoring device monitors values of one or more physiological parameters of the patient instead of, or in addition to, a therapy delivering medical device. The monitor may include a processor 46 and memory 48, and may be coupled to or include sensors 40, as illustrated above with reference to IMD 14 and FIGS. 2 and 3. The monitor may determine whether the patient is attempting to sleep, determine values for sleep quality metrics, determine activity metric values, and/or periodically determine activity levels based on the values of the monitored physiological parameter values, or may transmit activity levels or the physiological parameter values to a computing device for determination of whether the patient is attempting to sleep, values for sleep quality metrics, and/or activity metric values.
  • In embodiments in which the medical device determines sleep quality and activity metric values, the medical device may identify the current therapy parameter set when a value of one or more sleep quality or activity metrics is collected, and may associate that value with the therapy parameter set. In embodiments in which a programming device or other computing device determines activity levels, or activity or sleep quality metric values, the medical device may associate recorded physiological parameter values or activity levels with the current therapy parameter set in the memory. Further, in embodiments in which a separate monitoring device records physiological parameter values, determines activity levels, or determines activity or sleep quality metric values, the monitoring device may mark recorded physiological parameter values, activity levels, or activity or sleep quality metric values with a current time in a memory, and the medical device may store an indication of a current therapy parameter set and time in a memory. A programming device of other computing device may receive indications of the physiological parameter values, activity levels, or activity or sleep quality metric values and associated times from the monitoring device, and indications of the therapy parameter sets and associated times from the medical device, and may associate the physiological parameter values, activity levels, or activity or sleep quality metric values with the therapy parameter set that was delivered by the medical device when the values or levels were recorded.
  • FIG. 11 is a conceptual diagram illustrating a monitor 150 that monitors values of one or more physiological parameters of the patient instead of, or in addition to, a therapy delivering medical device. In the illustrated example, monitor 150 is configured to be attached to or otherwise carried by a belt 152, and may thereby be worn by patient 12. FIG. 11 also illustrates various sensors 40 that may be coupled to monitor 150 by leads, wires, cables, or wireless connections, such as EEG electrodes 154A-C placed on the scalp of patient 12, a plurality of EOG electrodes 156A and 156B placed proximate to the eyes of patient 12, and one or more EMG electrodes 158 placed on the chin or jaw the patient. The number and positions of electrodes 154, 156 and 158 illustrated in FIG. 11 are merely exemplary. For example, although only three EEG electrodes 154 are illustrated in FIG. 1, an array of between 16 and 25 EEG electrodes 114 may be placed on the scalp of patient 12, as is known in the art. EEG electrodes 154 may be individually placed on patient 12, or integrated within a cap or hair net worn by the patient.
  • In the illustrated example, patient 12 wears an ECG belt 160. ECG belt 160 incorporates a plurality of electrodes for sensing the electrical activity of the heart of patient 12. The heart rate and, in some embodiments, ECG morphology of patient 12 may monitored by monitor 150 based on the signal provided by ECG belt 160. Examples of suitable belts 160 for sensing the heart rate of patient 12 are the “M” and “F” heart rate monitor models commercially available from Polar Electro. In some embodiments, instead of belt 160, patient 12 may wear of plurality of ECG electrodes attached, e.g., via adhesive patches, at various locations on the chest of the patient, as is known in the art. An ECG signal derived from the signals sensed by such an array of electrodes may enable both heart rate and ECG morphology monitoring, as is known in the art.
  • As shown in FIG. 11, patient 12 may also wear a respiration belt 162 that outputs a signal that varies as a function of respiration of the patient. Respiration belt 162 may be a plethysmograpy belt, and the signal output by respiration belt 162 may vary as a function of the changes is the thoracic or abdominal circumference of patient 12 that accompany breathing by the patient. An example of a suitable belt 162 is the TSD201 Respiratory Effort Transducer commercially available from Biopac Systems, Inc. Alternatively, respiration belt 162 may incorporate or be replaced by a plurality of electrodes that direct an electrical signal through the thorax of the patient, and circuitry to sense the impedance of the thorax, which varies as a function of respiration of the patient, based on the signal. In some embodiments, ECG and respiration belts 160 and 162 may be a common belt worn by patient 12, and the relative locations of belts 160 and 162 depicted in FIG. 11 are merely exemplary.
  • In the example illustrated by FIG. 11, patient 12 also wears a transducer 164 that outputs a signal as a function of the oxygen saturation of the blood of patient 12. Transducer 164 may be an infrared transducer. Transducer 164 may be located on one of the fingers or earlobes of patient 12. Monitor 150 may additionally or alternatively include or be coupled to any of the variety of sensors 40 described above with reference to FIGS. 2 and 3, which output signals which vary as a function of any one or more of activity level, posture, heart rate, ECG morphology, respiration rate, respiratory volume, blood pressure, blood oxygen saturation, partial pressure of oxygen within blood, partial pressure of oxygen within cerebrospinal fluid, muscular activity and tone, core temperature, subcutaneous temperature, arterial blood flow, brain electrical activity, eye motion, and galvanic skin response, as described above.
  • The invention may also be embodied as a computer-readable medium that includes instructions to cause a processor to perform any of the methods described herein. These and other embodiments are within the scope of the following claims.

Claims (15)

  1. 1. A method comprising:
    monitoring a plurality of physiological parameters of a patient, wherein the plurality of physiological parameters includes at least one parameter indicative of patient physical activity;
    determining when the patient is attempting to sleep;
    determining values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep; and
    periodically determining an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep,
    wherein monitoring a plurality of physiological parameters comprises monitoring at least one of electrocardiogram morphology, subcutaneous temperature, muscular tone, brain electrical activity, or eye motion.
  2. 2. A medical system comprising:
    a device that monitors a plurality of physiological parameters of a patient, wherein the plurality of physiological parameters includes at least one physiological parameter indicative of patient physical activity; and
    a processor that determines when the patient is attempting to sleep, determines values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep, and periodically determines an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep.
  3. 3. The medical system of claim 2, wherein the device monitors at least one of electrocardiogram morphology, subcutaneous temperature, muscular tone, brain electrical activity, or eye motion.
  4. 4. The medical system of claim 2,
    wherein the device that monitors a plurality of physiological parameters of a patient comprises a first device,
    the system further comprising a second device that delivers a therapy to the patient according to a plurality of therapy parameter sets,
    wherein the processor associates each of the determined sleep quality metric value and each of the determined activity levels with a current therapy parameter set,
    wherein, for each of the plurality of therapy parameter sets, the processor determines a representative value of each of the at least one sleep quality metric based on the sleep quality metric values associated with the therapy parameter set, and
    wherein, for each of the plurality of therapy parameter sets, the processor determines at least one activity metric value based on the activity levels associated with the therapy parameter set.
  5. 5. The medical system of claim 4, further comprising a computing device including a display that presents a list of the therapy parameter sets, associated representative sleep quality metric values, and associated activity metric values.
  6. 6. The medical system of claim 5, wherein the computing device receives user selection of one of the sleep quality metrics and activity metric, and orders the list of therapy parameter sets according to values of the user selected one of the sleep quality metrics and activity metrics.
  7. 7. The medical system of claim 4, wherein the first and second device comprise a single device.
  8. 8. The medical system of claim 2, wherein the processor comprises a processor of the device that monitors a plurality of physiological parameters of the patient.
  9. 9. The medical system of claim 2, further comprising a computing device, wherein the processor comprises a processor of the computing device.
  10. 10. The medical system of claim 2, wherein the device that monitors a plurality of physiological parameters of the patient comprises an implantable medical device.
  11. 11. The medical system of claim 10, wherein the implantable medical device comprises at least one of an implantable neurostimulator and an implantable drug pump.
  12. 12. The medical system of claim 2, wherein the device that monitors a plurality of physiological parameters of the patient comprises at least one of a trial neurostimulator and a trial pump.
  13. 13. A medical system comprising:
    means for monitoring a plurality of physiological parameters of a patient, wherein the plurality of physiological parameters includes at least one parameter indicative of patient physical activity;
    means for determining when the patient is attempting to sleep;
    means for determining values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep; and
    means for periodically determining an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep
    wherein means for monitoring a plurality of physiological parameters comprises means for monitoring at least one of electrocardiogram morphology, subcutaneous temperature, muscular tone, brain electrical activity, or eye motion.
  14. 14. A medical system comprising:
    an implantable medical device that delivers a therapy to a patient based on a plurality of therapy parameter sets, monitors a plurality of physiological parameters of the patient including at least one parameter indicative of patient physical activity, determines when the patient is attempting to sleep, determines values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep, periodically determines an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep, associates each determined sleep quality metric value and each determined activity level with a current therapy parameter set, determines a representative value of each of the at least one sleep quality metrics for each of the plurality of therapy parameter sets based on the sleep quality metric values associated with the therapy parameter set, and determines at least one activity metric value for each of the plurality of therapy parameter sets based on the activity levels associated with the therapy parameter set; and
    an external programming device including a display that receives information identifying the plurality of therapy parameter sets and the sleep quality metric values and activity metric values associated with the therapy parameter sets from the implantable medical device, and presents a list of the therapy parameter sets and the associated sleep quality metric values and activity metric values to a user,
    wherein the implantable medical device monitors at least one of electrocardiogram morphology, subcutaneous temperature, muscular tone, brain electrical activity, or eye motion.
  15. 15. A computer-readable medium comprising instructions that cause a programmable processor to:
    monitor a plurality of physiological parameters of a patient, wherein the plurality of physiological parameters includes at least one parameter indicative of patient physical activity;
    determine when the patient is attempting to sleep;
    determine values of at least one metric that is indicative of sleep quality based on at least one of the physiological parameters and a determination that the patient is attempting to sleep; and
    periodically determine an activity level of the patient based on at least one of the physiological parameters and a determination that the patient is not attempting to sleep
    wherein the instructions that cause a programmable processor to monitor a plurality of physiological parameters of a patient comprise instructions that cause the programmable processor to monitor at least one of electrocardiogram morphology, subcutaneous temperature, muscular tone, brain electrical activity, or eye motion.
US11081857 2004-03-16 2005-03-16 Collecting activity and sleep quality information via a medical device Abandoned US20050234518A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US55378504 true 2004-03-16 2004-03-16
US10825955 US7491181B2 (en) 2004-03-16 2004-04-15 Collecting activity and sleep quality information via a medical device
US11081857 US20050234518A1 (en) 2004-03-16 2005-03-16 Collecting activity and sleep quality information via a medical device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11081857 US20050234518A1 (en) 2004-03-16 2005-03-16 Collecting activity and sleep quality information via a medical device
US11691425 US8308661B2 (en) 2004-03-16 2007-03-26 Collecting activity and sleep quality information via a medical device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10825955 Continuation-In-Part US7491181B2 (en) 2004-03-16 2004-04-15 Collecting activity and sleep quality information via a medical device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11691425 Continuation-In-Part US8308661B2 (en) 2004-03-16 2007-03-26 Collecting activity and sleep quality information via a medical device

Publications (1)

Publication Number Publication Date
US20050234518A1 true true US20050234518A1 (en) 2005-10-20

Family

ID=34963063

Family Applications (3)

Application Number Title Priority Date Filing Date
US10825955 Active 2024-09-20 US7491181B2 (en) 2004-03-16 2004-04-15 Collecting activity and sleep quality information via a medical device
US11081857 Abandoned US20050234518A1 (en) 2004-03-16 2005-03-16 Collecting activity and sleep quality information via a medical device
US12351414 Active 2025-08-17 US8337431B2 (en) 2004-03-16 2009-01-09 Collecting activity and sleep quality information via a medical device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10825955 Active 2024-09-20 US7491181B2 (en) 2004-03-16 2004-04-15 Collecting activity and sleep quality information via a medical device

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12351414 Active 2025-08-17 US8337431B2 (en) 2004-03-16 2009-01-09 Collecting activity and sleep quality information via a medical device

Country Status (4)

Country Link
US (3) US7491181B2 (en)
EP (1) EP1732442B1 (en)
DE (1) DE602005017755D1 (en)
WO (1) WO2005089647A1 (en)

Cited By (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030074028A1 (en) * 2001-10-13 2003-04-17 Biotronik Mess-Und Therapiegeraete Gmbh Ingenieurbuero Berlin Arrangement for predicting tacharrhythmia
US20050222643A1 (en) * 2004-03-16 2005-10-06 Heruth Kenneth T Collecting activity information to evaluate therapy
US20050234514A1 (en) * 2004-03-16 2005-10-20 Heruth Kenneth T Collecting posture information to evaluate therapy
US20050245988A1 (en) * 2004-04-14 2005-11-03 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US20070015976A1 (en) * 2005-06-01 2007-01-18 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US20070123758A1 (en) * 2004-03-16 2007-05-31 Medtronic, Inc. Determination of sleep quality for neurological disorders
US20070129769A1 (en) * 2005-12-02 2007-06-07 Medtronic, Inc. Wearable ambulatory data recorder
US20080009837A1 (en) * 2003-10-02 2008-01-10 Medtronic, Inc. Pressure sensing in implantable medical devices
US20080139955A1 (en) * 2006-12-07 2008-06-12 Drager Medical Ag & Co. Kg Device and method for determining a respiration rate
US20080243074A1 (en) * 2007-03-30 2008-10-02 Miesel Keith A Catheter malfunction determinations using physiologic pressure
US20090082639A1 (en) * 2007-09-25 2009-03-26 Pittman Stephen D Automated Sleep Phenotyping
US20090156908A1 (en) * 2007-12-14 2009-06-18 Transoma Medical, Inc. Deriving Patient Activity Information from Sensed Body Electrical Information
US20100042174A1 (en) * 2008-08-12 2010-02-18 Pacesetter, Inc. Selecting pacing site or sites based on cardio-pulmonary information
US20100113961A1 (en) * 2005-06-29 2010-05-06 St. Jude Medical Ab Medical device for determining the posture of patient
US7764996B2 (en) 2006-10-31 2010-07-27 Cardiac Pacemakers, Inc. Monitoring of chronobiological rhythms for disease and drug management using one or more implantable device
US7775993B2 (en) 2004-03-16 2010-08-17 Medtronic, Inc. Detecting sleep
US7792583B2 (en) 2004-03-16 2010-09-07 Medtronic, Inc. Collecting posture information to evaluate therapy
US20100234697A1 (en) * 2008-04-29 2010-09-16 Lotus Magnus, Llc Systems, devices, and methods for monitoring a subject
US7805196B2 (en) 2004-03-16 2010-09-28 Medtronic, Inc. Collecting activity information to evaluate therapy
US7809420B2 (en) 2003-06-25 2010-10-05 Nellcor Puritan Bennett Llc Hat-based oximeter sensor
US7822453B2 (en) 2002-10-01 2010-10-26 Nellcor Puritan Bennett Llc Forehead sensor placement
US20110015469A1 (en) * 2008-04-09 2011-01-20 Lotus Magnus, Llc. Brain stimulation systems and methods
US7881798B2 (en) 2004-03-16 2011-02-01 Medtronic Inc. Controlling therapy based on sleep quality
US8032224B2 (en) 2004-03-16 2011-10-04 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US8055348B2 (en) 2004-03-16 2011-11-08 Medtronic, Inc. Detecting sleep to evaluate therapy
US8135473B2 (en) 2004-04-14 2012-03-13 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US8150531B2 (en) 2008-07-11 2012-04-03 Medtronic, Inc. Associating therapy adjustments with patient posture states
US20120109251A1 (en) * 2006-03-23 2012-05-03 Valery Pavlovich Lebedev Transcranial electrostimulation device
US8175720B2 (en) 2009-04-30 2012-05-08 Medtronic, Inc. Posture-responsive therapy control based on patient input
US8209028B2 (en) 2008-07-11 2012-06-26 Medtronic, Inc. Objectification of posture state-responsive therapy based on patient therapy adjustments
US8219206B2 (en) 2008-07-11 2012-07-10 Medtronic, Inc. Dwell time adjustments for posture state-responsive therapy
US8231555B2 (en) 2009-04-30 2012-07-31 Medtronic, Inc. Therapy system including multiple posture sensors
US8257274B2 (en) 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8280517B2 (en) 2008-09-19 2012-10-02 Medtronic, Inc. Automatic validation techniques for validating operation of medical devices
US8308661B2 (en) 2004-03-16 2012-11-13 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US8317770B2 (en) 2006-04-06 2012-11-27 Medtronic, Inc. Systems and methods of identifying catheter malfunctions using pressure sensing
US8332041B2 (en) 2008-07-11 2012-12-11 Medtronic, Inc. Patient interaction with posture-responsive therapy
US8335568B2 (en) 2004-03-16 2012-12-18 Medtronic, Inc. Controlling therapy based on sleep quality
US8337431B2 (en) 2004-03-16 2012-12-25 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
WO2013002846A1 (en) 2011-06-27 2013-01-03 Medtronic, Inc. Devices and methods for detecting catheter complications
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
US8388555B2 (en) 2010-01-08 2013-03-05 Medtronic, Inc. Posture state classification for a medical device
US8396565B2 (en) 2003-09-15 2013-03-12 Medtronic, Inc. Automatic therapy adjustments
US8401666B2 (en) 2008-07-11 2013-03-19 Medtronic, Inc. Modification profiles for posture-responsive therapy
US8412297B2 (en) 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US8437861B2 (en) 2008-07-11 2013-05-07 Medtronic, Inc. Posture state redefinition based on posture data and therapy adjustments
US8504150B2 (en) 2008-07-11 2013-08-06 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8579834B2 (en) 2010-01-08 2013-11-12 Medtronic, Inc. Display of detected patient posture state
US8708934B2 (en) 2008-07-11 2014-04-29 Medtronic, Inc. Reorientation of patient posture states for posture-responsive therapy
US8744587B2 (en) 2006-03-24 2014-06-03 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US8758242B2 (en) 2004-03-16 2014-06-24 Medtronic, Inc. Collecting sleep quality information via a medical device
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
US9033920B2 (en) 2003-10-02 2015-05-19 Medtronic, Inc. Determining catheter status
US9050471B2 (en) 2008-07-11 2015-06-09 Medtronic, Inc. Posture state display on medical device user interface
US9069380B2 (en) 2011-06-10 2015-06-30 Aliphcom Media device, application, and content management using sensory input
US9138537B2 (en) * 2003-10-02 2015-09-22 Medtronic, Inc. Determining catheter status
US9327070B2 (en) 2009-04-30 2016-05-03 Medtronic, Inc. Medical device therapy based on posture and timing
US9333351B2 (en) 2013-12-16 2016-05-10 Pacesetter, Inc. Neurostimulation method and system to treat apnea
US9357949B2 (en) 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
US9566441B2 (en) 2010-04-30 2017-02-14 Medtronic, Inc. Detecting posture sensor signal shift or drift in medical devices
US9597032B2 (en) 2007-02-09 2017-03-21 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US9737719B2 (en) 2012-04-26 2017-08-22 Medtronic, Inc. Adjustment of therapy based on acceleration
US9907959B2 (en) 2012-04-12 2018-03-06 Medtronic, Inc. Velocity detection for posture-responsive therapy
US9956418B2 (en) 2010-01-08 2018-05-01 Medtronic, Inc. Graphical manipulation of posture zones for posture-responsive therapy

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070276439A1 (en) * 2004-03-16 2007-11-29 Medtronic, Inc. Collecting sleep quality information via a medical device
US20060019224A1 (en) * 2004-07-23 2006-01-26 Pics, Inc. Insomnia assessment and treatment device and method
US20090187121A1 (en) * 2008-01-22 2009-07-23 Camntech Limited Diary and method for medical monitoring
US20110009773A1 (en) * 2006-02-04 2011-01-13 Evigia Systems, Inc. Implantable sensing modules and methods of using
US20120179066A1 (en) * 2006-10-18 2012-07-12 Yuan Ze University Sleeping quality monitor system and a method for monitoring a physiological signal
US8306624B2 (en) * 2006-04-28 2012-11-06 Medtronic, Inc. Patient-individualized efficacy rating
US8617068B2 (en) * 2006-09-27 2013-12-31 ResMed Limitied Method and apparatus for assessing sleep quality
US8868183B2 (en) * 2006-12-21 2014-10-21 Cardiac Pacemakers, Inc. Method and apparatus to implement multiple parameter sets in an implantable device
US8200341B2 (en) 2007-02-07 2012-06-12 Cameron Health, Inc. Sensing vector selection in a cardiac stimulus device with postural assessment
US8805508B2 (en) * 2007-05-30 2014-08-12 Medtronic, Inc. Collecting activity data for evaluation of patient incontinence
US8204597B2 (en) * 2007-05-30 2012-06-19 Medtronic, Inc. Evaluating patient incontinence
WO2008154643A1 (en) 2007-06-12 2008-12-18 Triage Wireless, Inc. Vital sign monitor for measuring blood pressure using optical, electrical, and pressure waveforms
US8602997B2 (en) 2007-06-12 2013-12-10 Sotera Wireless, Inc. Body-worn system for measuring continuous non-invasive blood pressure (cNIBP)
US8380314B2 (en) 2007-09-26 2013-02-19 Medtronic, Inc. Patient directed therapy control
US20090264789A1 (en) * 2007-09-26 2009-10-22 Medtronic, Inc. Therapy program selection
US8768466B2 (en) * 2007-10-12 2014-07-01 Cardiac Pacemakers, Inc. Method and apparatus to trend and optimize an implantable medical device using a patient management system
WO2009051638A1 (en) 2007-10-16 2009-04-23 Medtronic, Inc. Therapy control based on a patient movement state
WO2009094050A1 (en) 2008-01-25 2009-07-30 Medtronic, Inc. Sleep stage detection
JP2011513037A (en) * 2008-03-13 2011-04-28 キャロロン カンパニーCarolon Company Health monitoring and management system
JP5518053B2 (en) * 2008-05-15 2014-06-11 インスパイア・メディカル・システムズ・インコーポレイテッドInspire Medical Systems, Inc. How to detect the respiration pressure in the implantable stimulation system and device
US8788042B2 (en) 2008-07-30 2014-07-22 Ecole Polytechnique Federale De Lausanne (Epfl) Apparatus and method for optimized stimulation of a neurological target
JP5547200B2 (en) 2008-10-01 2014-07-09 インスパイア・メディカル・システムズ・インコーポレイテッドInspire Medical Systems, Inc. Transvenous method for the treatment of sleep apnea
CA2743575C (en) 2008-11-12 2017-01-31 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
US8292819B2 (en) * 2008-11-17 2012-10-23 National Yang-Ming University Sleep analysis system and method for analyzing sleep thereof
JP5575789B2 (en) 2008-11-19 2014-08-20 インスパイア・メディカル・システムズ・インコーポレイテッドInspire Medical Systems, Inc. A method of treatment of sleep-disordered breathing
US8353828B2 (en) * 2008-11-21 2013-01-15 Yuan Ze University Remote sleep quality detecting system and method thereof
EP2416845B1 (en) 2009-03-31 2015-03-18 Inspire Medical Systems, Inc. Percutaneous access for systems of treating sleep-related disordered breathing
WO2010132311A9 (en) * 2009-05-13 2011-01-06 Monitoring Information Technologies, Inc. Systems and methods for heart and activity monitoring
US8475370B2 (en) 2009-05-20 2013-07-02 Sotera Wireless, Inc. Method for measuring patient motion, activity level, and posture along with PTT-based blood pressure
US20100298661A1 (en) * 2009-05-20 2010-11-25 Triage Wireless, Inc. Method for generating alarms/alerts based on a patient's posture and vital signs
US20100324387A1 (en) 2009-06-17 2010-12-23 Jim Moon Body-worn pulse oximeter
US8740807B2 (en) 2009-09-14 2014-06-03 Sotera Wireless, Inc. Body-worn monitor for measuring respiration rate
US8527038B2 (en) 2009-09-15 2013-09-03 Sotera Wireless, Inc. Body-worn vital sign monitor
US8321004B2 (en) 2009-09-15 2012-11-27 Sotera Wireless, Inc. Body-worn vital sign monitor
US8364250B2 (en) 2009-09-15 2013-01-29 Sotera Wireless, Inc. Body-worn vital sign monitor
US9770204B2 (en) 2009-11-11 2017-09-26 Medtronic, Inc. Deep brain stimulation for sleep and movement disorders
WO2011067297A9 (en) 2009-12-01 2012-04-05 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Microfabricated surface neurostimulation device and methods of making and using the same
US8348840B2 (en) * 2010-02-04 2013-01-08 Robert Bosch Gmbh Device and method to monitor, assess and improve quality of sleep
EP2545475A1 (en) * 2010-03-08 2013-01-16 Koninklijke Philips Electronics N.V. System and method for obtaining an objective measure of dyspnea
US20110224498A1 (en) 2010-03-10 2011-09-15 Sotera Wireless, Inc. Body-worn vital sign monitor
WO2011114526A1 (en) * 2010-03-19 2011-09-22 富士通株式会社 Bruxism detection device, bruxism detection method, and computer program for detecting bruxism
JP5927176B2 (en) 2010-04-01 2016-06-01 エコーレ ポリテクニーク フェデラーレ デ ローザンヌ (イーピーエフエル) Device for interacting with nerve tissue, and methods of making and using it
US8888700B2 (en) 2010-04-19 2014-11-18 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US9173594B2 (en) 2010-04-19 2015-11-03 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8979765B2 (en) 2010-04-19 2015-03-17 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8747330B2 (en) 2010-04-19 2014-06-10 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US9173593B2 (en) 2010-04-19 2015-11-03 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US9339209B2 (en) 2010-04-19 2016-05-17 Sotera Wireless, Inc. Body-worn monitor for measuring respiratory rate
US8649871B2 (en) 2010-04-29 2014-02-11 Cyberonics, Inc. Validity test adaptive constraint modification for cardiac data used for detection of state changes
US8562536B2 (en) 2010-04-29 2013-10-22 Flint Hills Scientific, Llc Algorithm for detecting a seizure from cardiac data
US8831732B2 (en) 2010-04-29 2014-09-09 Cyberonics, Inc. Method, apparatus and system for validating and quantifying cardiac beat data quality
US8397578B2 (en) 2010-06-03 2013-03-19 Medtronic, Inc. Capacitive pressure sensor assembly
US9737657B2 (en) 2010-06-03 2017-08-22 Medtronic, Inc. Implantable medical pump with pressure sensor
US8641646B2 (en) 2010-07-30 2014-02-04 Cyberonics, Inc. Seizure detection using coordinate data
US9211411B2 (en) 2010-08-26 2015-12-15 Medtronic, Inc. Therapy for rapid eye movement behavior disorder (RBD)
US8571643B2 (en) 2010-09-16 2013-10-29 Flint Hills Scientific, Llc Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US8337404B2 (en) 2010-10-01 2012-12-25 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8684921B2 (en) 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US8382667B2 (en) 2010-10-01 2013-02-26 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8433419B2 (en) 2010-10-13 2013-04-30 Cardiac Pacemakers, Inc. Method and apparatus for controlling neurostimulation according to physical state
US20140249440A1 (en) 2010-12-28 2014-09-04 Matt Banet Body-worn system for continuous, noninvasive measurement of cardiac output, stroke volume, cardiac power, and blood pressure
CN103582449B (en) 2011-02-18 2017-06-09 索泰拉无线公司 Modular wrist-worn processor for patient monitoring of
US9504390B2 (en) 2011-03-04 2016-11-29 Globalfoundries Inc. Detecting, assessing and managing a risk of death in epilepsy
US8725239B2 (en) 2011-04-25 2014-05-13 Cyberonics, Inc. Identifying seizures using heart rate decrease
US9402550B2 (en) 2011-04-29 2016-08-02 Cybertronics, Inc. Dynamic heart rate threshold for neurological event detection
US20120316932A1 (en) * 2011-06-10 2012-12-13 Aliphcom Wellness application for data-capable band
US8660517B2 (en) 2011-10-07 2014-02-25 Jason Paul DeMont Personal assistance monitoring system
US20130165819A1 (en) * 2011-12-23 2013-06-27 Pacesetter, Inc. System and method for controlling radio frequency scanning attributes of an implantable medical device
US9681836B2 (en) 2012-04-23 2017-06-20 Cyberonics, Inc. Methods, systems and apparatuses for detecting seizure and non-seizure states
WO2013173102A1 (en) 2012-05-18 2013-11-21 Cardiac Pacemakers, Inc. Automatic pacing configuration switcher
US9993179B2 (en) * 2012-10-29 2018-06-12 Nightbalance B.V. Method and device for sleep posture correction
US9446243B2 (en) 2012-12-07 2016-09-20 Boston Scientific Neuromodulation Corporation Patient posture determination and stimulation program adjustment in an implantable stimulator device using impedance fingerprinting
US20160287168A1 (en) * 2014-01-02 2016-10-06 Intel Corporation (A Corporation Of Delaware) Identifying and characterizing nocturnal motion and stages of sleep
US9821162B2 (en) 2014-04-25 2017-11-21 Medtronic, Inc. Deep brain stimulation for sleep disorders
US9694156B2 (en) 2014-06-05 2017-07-04 Eight Sleep Inc. Bed device system and methods
WO2015188156A1 (en) 2014-06-05 2015-12-10 Morphy Inc. Methods and systems for gathering human biological signals and controlling a bed device
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9808185B2 (en) 2014-09-23 2017-11-07 Fitbit, Inc. Movement measure generation in a wearable electronic device
WO2017134587A1 (en) 2016-02-02 2017-08-10 Aleva Neurotherapeutics, Sa Treatment of autoimmune diseases with deep brain stimulation
JP2017045475A (en) * 2016-11-22 2017-03-02 株式会社北電子 An information processing system and an information processing program

Citations (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297685A (en) * 1979-05-31 1981-10-27 Environmental Devices Corporation Apparatus and method for sleep detection
US4543955A (en) * 1983-08-01 1985-10-01 Cordis Corporation System for controlling body implantable action device
US4617525A (en) * 1984-01-30 1986-10-14 Lloyd Stephen R Sleep posture monitor and alarm system
US5059576A (en) * 1988-12-21 1991-10-22 Babcock-Hitachi Kabushiki Kaisha Catalyst for removing nitrogen oxides and a process for producing the same
US5125412A (en) * 1990-07-23 1992-06-30 Thornton William E Musculoskeletal activity monitor
US5275159A (en) * 1991-03-22 1994-01-04 Madaus Schwarzer Medizintechnik Gmbh & Co. Kg Method and apparatus for diagnosis of sleep disorders
US5335657A (en) * 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
US5337758A (en) * 1991-01-11 1994-08-16 Orthopedic Systems, Inc. Spine motion analyzer and method
US5469861A (en) * 1992-04-17 1995-11-28 Mark F. Piscopo Posture monitor
US5514162A (en) * 1994-06-07 1996-05-07 Pacesetter, Inc. System and method for automatically determining the slope of a transfer function for a rate-responsive cardiac pacemaker
US5593431A (en) * 1995-03-30 1997-01-14 Medtronic, Inc. Medical service employing multiple DC accelerometers for patient activity and posture sensing and method
US5645053A (en) * 1991-11-14 1997-07-08 University Technologies International, Inc. Auto CPAP system and method for preventing patient disturbance using airflow profile information
US5732696A (en) * 1992-03-17 1998-03-31 New York University Polysomnograph scoring
US5832932A (en) * 1996-04-30 1998-11-10 Medtronic, Inc. Method of treating movement disorders by brain infusion
US5895371A (en) * 1996-08-27 1999-04-20 Sabratek Corporation Medical treatment apparatus and method
US5904780A (en) * 1996-05-02 1999-05-18 Tokyo Electron Limited Plasma processing apparatus
US5904708A (en) * 1998-03-19 1999-05-18 Medtronic, Inc. System and method for deriving relative physiologic signals
US5919149A (en) * 1996-03-19 1999-07-06 Allum; John H. Method and apparatus for angular position and velocity based determination of body sway for the diagnosis and rehabilitation of balance and gait disorders
US5999846A (en) * 1995-11-08 1999-12-07 Oxford Medical Limited Physiological monitoring
US6045513A (en) * 1998-05-13 2000-04-04 Medtronic, Inc. Implantable medical device for tracking patient functional status
US6095991A (en) * 1998-07-23 2000-08-01 Individual Monitoring Systems, Inc. Ambulatory body position monitor
US6120467A (en) * 1998-04-30 2000-09-19 Medtronic Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
US6165143A (en) * 1998-03-17 2000-12-26 Van Lummel; R. C. Method for measuring and indicating the extent to which an individual is limited in daily life activities
US6273856B1 (en) * 1999-10-19 2001-08-14 Cardiac Pacemakers, Inc. Apparatus and methods for METS measurement by accelerometer and minute ventilation sensors
US6296606B1 (en) * 1993-12-17 2001-10-02 Charles Goldberg Patient thermal support device
US20010031930A1 (en) * 1999-12-19 2001-10-18 Roizen Michael F. Alarm upon detection of impending sleep state
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US20020077562A1 (en) * 2000-12-15 2002-06-20 James Kalgren System and method for correlation of patient health information and implant device data
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US20020091308A1 (en) * 2001-01-09 2002-07-11 Kipshidze Nicholas N. Method and apparatus for the synchronized therapeutic treatment of a life form
US6459934B1 (en) * 2000-07-21 2002-10-01 Cardiac Pacemakers, Inc. Estimate of efficiency using acceleration-heart rate ratio
US20020161412A1 (en) * 2001-04-25 2002-10-31 Cardiac Pacemakers, Inc. Determination of long-term condition of cardiac patients
US20020169485A1 (en) * 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US20020193839A1 (en) * 2001-06-07 2002-12-19 Cho Yong Kyun Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same
US20020193697A1 (en) * 2001-04-30 2002-12-19 Cho Yong Kyun Method and apparatus to detect and treat sleep respiratory events
US20030004423A1 (en) * 2000-03-02 2003-01-02 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
US6514218B2 (en) * 2000-01-07 2003-02-04 Minolta Co., Ltd. Posture detecting device and breathing function measuring device
US6539249B1 (en) * 1998-05-11 2003-03-25 Cardiac Pacemakers, Inc. Method and apparatus for assessing patient well-being
US20030139692A1 (en) * 2000-02-04 2003-07-24 Eric Barrey Method for analysing irregularities in human locomotion
US20030149457A1 (en) * 2002-02-05 2003-08-07 Neuropace, Inc. Responsive electrical stimulation for movement disorders
US20030153953A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Stimulation device for sleep apnea prevention, detection and treatment
US20030163059A1 (en) * 2001-12-07 2003-08-28 Yann Poezevera Discriminating between an awake phase and a sleep phase of a patient in an active implantable medical device
US20030195588A1 (en) * 2002-04-16 2003-10-16 Neuropace, Inc. External ear canal interface for the treatment of neurological disorders
US20030212445A1 (en) * 2002-05-13 2003-11-13 Weinberg Lisa P. Implantable neural stimulation device providing activity, rest, and long term closed-loop peripheral vascular disease therapy and method
US6659968B1 (en) * 2000-06-01 2003-12-09 Advanced Bionics Corporation Activity monitor for pain management efficacy measurement
US20040002742A1 (en) * 2002-06-27 2004-01-01 Florio Joseph J. Using activity-based rest disturbance as a metric of sleep apnea
US20040015103A1 (en) * 2000-10-05 2004-01-22 Kamiar Aminian Body movement monitoring system and method
US20040049132A1 (en) * 2000-06-15 2004-03-11 The Procter & Gamble Company Device for body activity detection and processing
US20040102814A1 (en) * 2002-11-22 2004-05-27 Chris Sorensen Physician programmer system with telemetered sensor waveform
US20040111040A1 (en) * 2002-12-04 2004-06-10 Quan Ni Detection of disordered breathing
US6752766B2 (en) * 2001-01-30 2004-06-22 Peter Kowallik Method and device for sleep monitoring
US20040199214A1 (en) * 2002-12-17 2004-10-07 Merfeld Daniel M. Vestibular stimulator
US20050021103A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050021104A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050042589A1 (en) * 2003-08-18 2005-02-24 Hatlestad John D. Sleep quality data collection and evaluation
US20050039745A1 (en) * 2003-08-18 2005-02-24 Stahmann Jeffrey E. Adaptive therapy for disordered breathing
US20050060001A1 (en) * 2003-09-15 2005-03-17 Ruchika Singhal Automatic therapy adjustments
US20050061320A1 (en) * 2003-09-18 2005-03-24 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US20050065560A1 (en) * 2003-09-18 2005-03-24 Cardiac Pacemakers, Inc. Snoring detection system and method
US6878121B2 (en) * 2002-11-01 2005-04-12 David T. Krausman Sleep scoring apparatus and method
US20050080463A1 (en) * 2003-09-18 2005-04-14 Stahmann Jeffrey E. System and method for detecting an involuntary muscle movement disorder
US20050076908A1 (en) * 2003-09-18 2005-04-14 Kent Lee Autonomic arousal detection system and method
US6881192B1 (en) * 2002-06-12 2005-04-19 Pacesetter, Inc. Measurement of sleep apnea duration and evaluation of response therapies using duration metrics
US20050085738A1 (en) * 2003-09-18 2005-04-21 Stahmann Jeffrey E. Sleep logbook
US6884596B2 (en) * 2000-04-28 2005-04-26 The Regents Of The University Of California Screening and therapeutic methods for promoting wakefulness and sleep
US6890306B2 (en) * 2001-12-14 2005-05-10 Ela Medical S.A. Active medical device for the diagnosis of the sleep apnea syndrome
US20050113710A1 (en) * 2003-09-18 2005-05-26 Stahmann Jeffrey E. Implantable device employing movement sensing for detecting sleep-related disorders
US20050119703A1 (en) * 1998-08-05 2005-06-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050143617A1 (en) * 2003-12-31 2005-06-30 Raphael Auphan Sleep and environment control method and system
US20050177192A1 (en) * 2002-02-01 2005-08-11 Ali Rezai Neurostimulation for affecting sleep disorders
US20050215847A1 (en) * 2004-03-16 2005-09-29 Heruth Kenneth T Collecting sleep quality information via a medical device
US20050222626A1 (en) * 1998-08-05 2005-10-06 Dilorenzo Daniel J Cloosed-loop feedback-driven neuromodulation
US20050240242A1 (en) * 1998-08-05 2005-10-27 Dilorenzo Daniel J Closed-loop feedback-driven neuromodulation
US20050240086A1 (en) * 2004-03-12 2005-10-27 Metin Akay Intelligent wearable monitor systems and methods
US20050245790A1 (en) * 2002-10-04 2005-11-03 Henrik Bergfalk Detection of psychological disorder activity patterns
US20060224191A1 (en) * 1998-08-05 2006-10-05 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state
US20060293720A1 (en) * 1998-08-05 2006-12-28 Dilorenzo Daniel J Closed-loop feedback-driven neuromodulation
US7162304B1 (en) * 2003-05-08 2007-01-09 Advanced Bionics Corporation System for measuring cardiac rhythm parameters for assessment of spinal cord stimulation
US20070142862A1 (en) * 1998-08-05 2007-06-21 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1213330A (en) * 1983-10-14 1986-10-28 Roger Broughton Movement artifact detector for sleep analysis
US4771780A (en) * 1987-01-15 1988-09-20 Siemens-Pacesetter, Inc. Rate-responsive pacemaker having digital motion sensor
DE3709073C2 (en) * 1987-03-19 1990-09-06 Eckhard Dr. 8000 Muenchen De Alt
US4776345A (en) * 1987-09-04 1988-10-11 Cns, Inc. Interactive determination of sleep stages
US5278190A (en) 1989-11-30 1994-01-11 Clintec Nutrition Co. Method for improving the quality of sleep and treating sleep disorders
FR2657443B1 (en) * 1990-01-24 1992-05-15 Blanchet Gerard Method and processing apparatus of electroencephalographic signal.
US5040536A (en) * 1990-01-31 1991-08-20 Medtronic, Inc. Intravascular pressure posture detector
US5031618A (en) * 1990-03-07 1991-07-16 Medtronic, Inc. Position-responsive neuro stimulator
US5058584A (en) * 1990-08-30 1991-10-22 Medtronic, Inc. Method and apparatus for epidural burst stimulation for angina pectoris
US5233984A (en) * 1991-03-29 1993-08-10 Medtronic, Inc. Implantable multi-axis position and activity sensor
US5476483A (en) * 1994-06-10 1995-12-19 Pacesetter, Inc. System and method for modulating the base rate during sleep for a rate-responsive cardiac pacemaker
FI100851B (en) 1994-08-15 1998-03-13 Polar Electro Oy Method and apparatus for the individual's body part at eröimiseen and ambulatory recording regist Simultaneously, as well as movements of the different body parts for monitoring the superposed
FR2728798B1 (en) * 1994-12-30 1997-06-20 Ela Medical Sa A method of determining an activity criterion of a sensor for measuring a control parameter in an active implantable medical device
WO1996032055A1 (en) * 1995-04-11 1996-10-17 Resmed Limited Monitoring the occurrence of apneic and hypopneic arousals
US5643332A (en) * 1995-09-20 1997-07-01 Neuromotion Inc. Assembly for functional electrical stimulation during movement
US5944680A (en) * 1996-06-26 1999-08-31 Medtronic, Inc. Respiratory effort detection method and apparatus
US5782884A (en) * 1996-11-05 1998-07-21 Sulzer Intermedics Inc. Rate responsive cardiac pacemaker with peak impedance detection for rate control
DE19653773C1 (en) 1996-12-21 1998-07-02 Ggt Ges Fuer Gerontotechnik Mb Method and device for detection of fall situations of persons with a risk to health
US5941906A (en) * 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
DE29719250U1 (en) 1997-10-30 1998-05-07 Hauptverband Der Gewerblichen Körperbelastungsmeß- and analysis system
US6059576A (en) * 1997-11-21 2000-05-09 Brann; Theodore L. Training and safety device, system and method to aid in proper movement during physical activity
US6128534A (en) * 1998-06-16 2000-10-03 Pacesetter, Inc. Implantable cardiac stimulation device and method for varying pacing parameters to mimic circadian cycles
FR2780654B1 (en) * 1998-07-06 2000-12-01 Ela Medical Sa Device for active implantable medical treatment by electrostimulation of the sleep apnea syndrome
DE19831109A1 (en) 1998-07-11 2000-01-13 Univ Schiller Jena Monitoring and evaluation of infants and new born breathing cycle
US6157857A (en) * 1998-07-24 2000-12-05 Dimpfel; Wilfried Apparatus for determining sleep staging
DE19842107A1 (en) * 1998-09-08 2000-03-09 Biotronik Mess & Therapieg Method for detecting the body position of a person
US6044297A (en) * 1998-09-25 2000-03-28 Medtronic, Inc. Posture and device orientation and calibration for implantable medical devices
US6160478A (en) * 1998-10-27 2000-12-12 Sarcos Lc Wireless health monitoring system
US6259948B1 (en) * 1998-11-13 2001-07-10 Pacesetter, Inc. Medical device
US6315740B1 (en) 1999-05-17 2001-11-13 Balbir Singh Seizure and movement monitoring apparatus
US6351672B1 (en) * 1999-07-22 2002-02-26 Pacesetter, Inc. System and method for modulating the pacing rate based on patient activity and position
US6449508B1 (en) * 1999-10-21 2002-09-10 Medtronic, Inc. Accelerometer count calculation for activity signal for an implantable medical device
US6466821B1 (en) * 1999-12-08 2002-10-15 Pacesetter, Inc. AC/DC multi-axis accelerometer for determining patient activity and body position
US6611783B2 (en) * 2000-01-07 2003-08-26 Nocwatch, Inc. Attitude indicator and activity monitoring device
US6572557B2 (en) * 2000-05-09 2003-06-03 Pacesetter, Inc. System and method for monitoring progression of cardiac disease state using physiologic sensors
DE10024103A1 (en) 2000-05-18 2001-11-29 Baumgart Schmitt Rudolf Arrangement for improving sleep quality by thermal stimulation has several thermoelectric units driven if sleep-related breathing problem automatically detected in real time
US6605038B1 (en) * 2000-06-16 2003-08-12 Bodymedia, Inc. System for monitoring health, wellness and fitness
US6687538B1 (en) * 2000-06-19 2004-02-03 Medtronic, Inc. Trial neuro stimulator with lead diagnostics
US6468234B1 (en) * 2000-07-14 2002-10-22 The Board Of Trustees Of The Leland Stanford Junior University SleepSmart
US6662047B2 (en) 2001-09-05 2003-12-09 Pacesetter, Inc. Pacing mode to reduce effects of orthostatic hypotension and syncope
US6751503B1 (en) 2001-11-01 2004-06-15 Pacesetter, Inc. Methods and systems for treating patients with congestive heart failure (CHF)
WO2003051356A1 (en) * 2001-12-17 2003-06-26 Merck & Co., Inc. Method for treating circadian rhythm disruptions
US6999817B2 (en) * 2002-02-14 2006-02-14 Packsetter, Inc. Cardiac stimulation device including sleep apnea prevention and treatment
US7043305B2 (en) * 2002-03-06 2006-05-09 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
US6922587B2 (en) * 2002-06-26 2005-07-26 Pacesetter, Inc. System and method for tracking progression of left ventricular dysfunction using implantable cardiac stimulation device
US7189204B2 (en) * 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
US7207947B2 (en) 2003-01-10 2007-04-24 Pacesetter, Inc. System and method for detecting circadian states using an implantable medical device
US7489970B2 (en) 2003-04-02 2009-02-10 Medtronic, Inc. Management of neurostimulation therapy using parameter sets
US6964641B2 (en) * 2003-12-24 2005-11-15 Medtronic, Inc. Implantable medical device with sleep disordered breathing monitoring
US7491181B2 (en) 2004-03-16 2009-02-17 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US20050209512A1 (en) * 2004-03-16 2005-09-22 Heruth Kenneth T Detecting sleep
US7395113B2 (en) * 2004-03-16 2008-07-01 Medtronic, Inc. Collecting activity information to evaluate therapy
US7330760B2 (en) 2004-03-16 2008-02-12 Medtronic, Inc. Collecting posture information to evaluate therapy
US7366572B2 (en) * 2004-03-16 2008-04-29 Medtronic, Inc. Controlling therapy based on sleep quality
US7542803B2 (en) * 2004-03-16 2009-06-02 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US7313440B2 (en) 2004-04-14 2007-12-25 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US20070046408A1 (en) * 2005-08-30 2007-03-01 Youngtack Shim Magnet-shunted systems and methods

Patent Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297685A (en) * 1979-05-31 1981-10-27 Environmental Devices Corporation Apparatus and method for sleep detection
US4543955A (en) * 1983-08-01 1985-10-01 Cordis Corporation System for controlling body implantable action device
US4617525A (en) * 1984-01-30 1986-10-14 Lloyd Stephen R Sleep posture monitor and alarm system
US5059576A (en) * 1988-12-21 1991-10-22 Babcock-Hitachi Kabushiki Kaisha Catalyst for removing nitrogen oxides and a process for producing the same
US5125412A (en) * 1990-07-23 1992-06-30 Thornton William E Musculoskeletal activity monitor
US5337758A (en) * 1991-01-11 1994-08-16 Orthopedic Systems, Inc. Spine motion analyzer and method
US5275159A (en) * 1991-03-22 1994-01-04 Madaus Schwarzer Medizintechnik Gmbh & Co. Kg Method and apparatus for diagnosis of sleep disorders
US5335657A (en) * 1991-05-03 1994-08-09 Cyberonics, Inc. Therapeutic treatment of sleep disorder by nerve stimulation
US5645053A (en) * 1991-11-14 1997-07-08 University Technologies International, Inc. Auto CPAP system and method for preventing patient disturbance using airflow profile information
US5732696A (en) * 1992-03-17 1998-03-31 New York University Polysomnograph scoring
US5469861A (en) * 1992-04-17 1995-11-28 Mark F. Piscopo Posture monitor
US6296606B1 (en) * 1993-12-17 2001-10-02 Charles Goldberg Patient thermal support device
US5514162A (en) * 1994-06-07 1996-05-07 Pacesetter, Inc. System and method for automatically determining the slope of a transfer function for a rate-responsive cardiac pacemaker
US5593431A (en) * 1995-03-30 1997-01-14 Medtronic, Inc. Medical service employing multiple DC accelerometers for patient activity and posture sensing and method
US20020169485A1 (en) * 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US5999846A (en) * 1995-11-08 1999-12-07 Oxford Medical Limited Physiological monitoring
US5919149A (en) * 1996-03-19 1999-07-06 Allum; John H. Method and apparatus for angular position and velocity based determination of body sway for the diagnosis and rehabilitation of balance and gait disorders
US5832932A (en) * 1996-04-30 1998-11-10 Medtronic, Inc. Method of treating movement disorders by brain infusion
US5904780A (en) * 1996-05-02 1999-05-18 Tokyo Electron Limited Plasma processing apparatus
US5895371A (en) * 1996-08-27 1999-04-20 Sabratek Corporation Medical treatment apparatus and method
US6165143A (en) * 1998-03-17 2000-12-26 Van Lummel; R. C. Method for measuring and indicating the extent to which an individual is limited in daily life activities
US5904708A (en) * 1998-03-19 1999-05-18 Medtronic, Inc. System and method for deriving relative physiologic signals
US6120467A (en) * 1998-04-30 2000-09-19 Medtronic Inc. Spinal cord simulation systems with patient activity monitoring and therapy adjustments
US6539249B1 (en) * 1998-05-11 2003-03-25 Cardiac Pacemakers, Inc. Method and apparatus for assessing patient well-being
US6045513A (en) * 1998-05-13 2000-04-04 Medtronic, Inc. Implantable medical device for tracking patient functional status
US6095991A (en) * 1998-07-23 2000-08-01 Individual Monitoring Systems, Inc. Ambulatory body position monitor
US20050119703A1 (en) * 1998-08-05 2005-06-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20070142862A1 (en) * 1998-08-05 2007-06-21 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state
US6819956B2 (en) * 1998-08-05 2004-11-16 Dilorenzo Daniel J. Optimal method and apparatus for neural modulation for the treatment of neurological disease, particularly movement disorders
US6366813B1 (en) * 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US20050240242A1 (en) * 1998-08-05 2005-10-27 Dilorenzo Daniel J Closed-loop feedback-driven neuromodulation
US20060224191A1 (en) * 1998-08-05 2006-10-05 Dilorenzo Daniel J Systems and methods for monitoring a patient's neurological disease state
US20050021103A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20020177882A1 (en) * 1998-08-05 2002-11-28 Dilorenzo Daniel J. Optimal method and apparatus for neural modulation for the treatment of neurological disease, particularly movement disorders
US20060293720A1 (en) * 1998-08-05 2006-12-28 Dilorenzo Daniel J Closed-loop feedback-driven neuromodulation
US20050021104A1 (en) * 1998-08-05 2005-01-27 Dilorenzo Daniel John Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20070073355A1 (en) * 1998-08-05 2007-03-29 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7209787B2 (en) * 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050222626A1 (en) * 1998-08-05 2005-10-06 Dilorenzo Daniel J Cloosed-loop feedback-driven neuromodulation
US6416471B1 (en) * 1999-04-15 2002-07-09 Nexan Limited Portable remote patient telemonitoring system
US6273856B1 (en) * 1999-10-19 2001-08-14 Cardiac Pacemakers, Inc. Apparatus and methods for METS measurement by accelerometer and minute ventilation sensors
US20010031930A1 (en) * 1999-12-19 2001-10-18 Roizen Michael F. Alarm upon detection of impending sleep state
US6514218B2 (en) * 2000-01-07 2003-02-04 Minolta Co., Ltd. Posture detecting device and breathing function measuring device
US20030139692A1 (en) * 2000-02-04 2003-07-24 Eric Barrey Method for analysing irregularities in human locomotion
US20030004423A1 (en) * 2000-03-02 2003-01-02 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
US6884596B2 (en) * 2000-04-28 2005-04-26 The Regents Of The University Of California Screening and therapeutic methods for promoting wakefulness and sleep
US6659968B1 (en) * 2000-06-01 2003-12-09 Advanced Bionics Corporation Activity monitor for pain management efficacy measurement
US20040049132A1 (en) * 2000-06-15 2004-03-11 The Procter & Gamble Company Device for body activity detection and processing
US6459934B1 (en) * 2000-07-21 2002-10-01 Cardiac Pacemakers, Inc. Estimate of efficiency using acceleration-heart rate ratio
US20040015103A1 (en) * 2000-10-05 2004-01-22 Kamiar Aminian Body movement monitoring system and method
US20020077562A1 (en) * 2000-12-15 2002-06-20 James Kalgren System and method for correlation of patient health information and implant device data
US20020091308A1 (en) * 2001-01-09 2002-07-11 Kipshidze Nicholas N. Method and apparatus for the synchronized therapeutic treatment of a life form
US6752766B2 (en) * 2001-01-30 2004-06-22 Peter Kowallik Method and device for sleep monitoring
US20020161412A1 (en) * 2001-04-25 2002-10-31 Cardiac Pacemakers, Inc. Determination of long-term condition of cardiac patients
US20020193697A1 (en) * 2001-04-30 2002-12-19 Cho Yong Kyun Method and apparatus to detect and treat sleep respiratory events
US20020193839A1 (en) * 2001-06-07 2002-12-19 Cho Yong Kyun Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same
US6773404B2 (en) * 2001-12-07 2004-08-10 Ela Medical S.A. Discriminating between an awake phase and a sleep phase of a patient in an active implantable medical device
US20030163059A1 (en) * 2001-12-07 2003-08-28 Yann Poezevera Discriminating between an awake phase and a sleep phase of a patient in an active implantable medical device
US6890306B2 (en) * 2001-12-14 2005-05-10 Ela Medical S.A. Active medical device for the diagnosis of the sleep apnea syndrome
US20050177192A1 (en) * 2002-02-01 2005-08-11 Ali Rezai Neurostimulation for affecting sleep disorders
US20030149457A1 (en) * 2002-02-05 2003-08-07 Neuropace, Inc. Responsive electrical stimulation for movement disorders
US6928324B2 (en) * 2002-02-14 2005-08-09 Pacesetter, Inc. Stimulation device for sleep apnea prevention, detection and treatment
US20030153953A1 (en) * 2002-02-14 2003-08-14 Euljoon Park Stimulation device for sleep apnea prevention, detection and treatment
US20030195588A1 (en) * 2002-04-16 2003-10-16 Neuropace, Inc. External ear canal interface for the treatment of neurological disorders
US20030212445A1 (en) * 2002-05-13 2003-11-13 Weinberg Lisa P. Implantable neural stimulation device providing activity, rest, and long term closed-loop peripheral vascular disease therapy and method
US6881192B1 (en) * 2002-06-12 2005-04-19 Pacesetter, Inc. Measurement of sleep apnea duration and evaluation of response therapies using duration metrics
US20040002742A1 (en) * 2002-06-27 2004-01-01 Florio Joseph J. Using activity-based rest disturbance as a metric of sleep apnea
US20050245790A1 (en) * 2002-10-04 2005-11-03 Henrik Bergfalk Detection of psychological disorder activity patterns
US6878121B2 (en) * 2002-11-01 2005-04-12 David T. Krausman Sleep scoring apparatus and method
US20040102814A1 (en) * 2002-11-22 2004-05-27 Chris Sorensen Physician programmer system with telemetered sensor waveform
US20040111040A1 (en) * 2002-12-04 2004-06-10 Quan Ni Detection of disordered breathing
US20040199214A1 (en) * 2002-12-17 2004-10-07 Merfeld Daniel M. Vestibular stimulator
US7162304B1 (en) * 2003-05-08 2007-01-09 Advanced Bionics Corporation System for measuring cardiac rhythm parameters for assessment of spinal cord stimulation
US20050039745A1 (en) * 2003-08-18 2005-02-24 Stahmann Jeffrey E. Adaptive therapy for disordered breathing
US20050042589A1 (en) * 2003-08-18 2005-02-24 Hatlestad John D. Sleep quality data collection and evaluation
US20050060001A1 (en) * 2003-09-15 2005-03-17 Ruchika Singhal Automatic therapy adjustments
US20050076908A1 (en) * 2003-09-18 2005-04-14 Kent Lee Autonomic arousal detection system and method
US20050113710A1 (en) * 2003-09-18 2005-05-26 Stahmann Jeffrey E. Implantable device employing movement sensing for detecting sleep-related disorders
US20050085738A1 (en) * 2003-09-18 2005-04-21 Stahmann Jeffrey E. Sleep logbook
US20050080463A1 (en) * 2003-09-18 2005-04-14 Stahmann Jeffrey E. System and method for detecting an involuntary muscle movement disorder
US20050065560A1 (en) * 2003-09-18 2005-03-24 Cardiac Pacemakers, Inc. Snoring detection system and method
US20050061320A1 (en) * 2003-09-18 2005-03-24 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US20050143617A1 (en) * 2003-12-31 2005-06-30 Raphael Auphan Sleep and environment control method and system
US20050240086A1 (en) * 2004-03-12 2005-10-27 Metin Akay Intelligent wearable monitor systems and methods
US20050215847A1 (en) * 2004-03-16 2005-09-29 Heruth Kenneth T Collecting sleep quality information via a medical device

Cited By (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030074028A1 (en) * 2001-10-13 2003-04-17 Biotronik Mess-Und Therapiegeraete Gmbh Ingenieurbuero Berlin Arrangement for predicting tacharrhythmia
US7181270B2 (en) * 2001-10-13 2007-02-20 Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingeniuerbuero Berlin Arrangement for predicting tachyarrhythmia
US7822453B2 (en) 2002-10-01 2010-10-26 Nellcor Puritan Bennett Llc Forehead sensor placement
US8452367B2 (en) 2002-10-01 2013-05-28 Covidien Lp Forehead sensor placement
US7899509B2 (en) 2002-10-01 2011-03-01 Nellcor Puritan Bennett Llc Forehead sensor placement
US7877126B2 (en) 2003-06-25 2011-01-25 Nellcor Puritan Bennett Llc Hat-based oximeter sensor
US7979102B2 (en) 2003-06-25 2011-07-12 Nellcor Puritan Bennett Llc Hat-based oximeter sensor
US7877127B2 (en) 2003-06-25 2011-01-25 Nellcor Puritan Bennett Llc Hat-based oximeter sensor
US7809420B2 (en) 2003-06-25 2010-10-05 Nellcor Puritan Bennett Llc Hat-based oximeter sensor
US7813779B2 (en) 2003-06-25 2010-10-12 Nellcor Puritan Bennett Llc Hat-based oximeter sensor
US8396565B2 (en) 2003-09-15 2013-03-12 Medtronic, Inc. Automatic therapy adjustments
US8412297B2 (en) 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US20080009837A1 (en) * 2003-10-02 2008-01-10 Medtronic, Inc. Pressure sensing in implantable medical devices
US9033920B2 (en) 2003-10-02 2015-05-19 Medtronic, Inc. Determining catheter status
US9138537B2 (en) * 2003-10-02 2015-09-22 Medtronic, Inc. Determining catheter status
US7955319B2 (en) 2003-10-02 2011-06-07 Medtronic, Inc. Pressure sensing in implantable medical devices
US8032224B2 (en) 2004-03-16 2011-10-04 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US8396554B2 (en) 2004-03-16 2013-03-12 Medtronic, Inc. Collecting posture information to evaluate therapy
US7775993B2 (en) 2004-03-16 2010-08-17 Medtronic, Inc. Detecting sleep
US7792583B2 (en) 2004-03-16 2010-09-07 Medtronic, Inc. Collecting posture information to evaluate therapy
US8758242B2 (en) 2004-03-16 2014-06-24 Medtronic, Inc. Collecting sleep quality information via a medical device
US7805196B2 (en) 2004-03-16 2010-09-28 Medtronic, Inc. Collecting activity information to evaluate therapy
US8725244B2 (en) 2004-03-16 2014-05-13 Medtronic, Inc. Determination of sleep quality for neurological disorders
US8308661B2 (en) 2004-03-16 2012-11-13 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US8332038B2 (en) 2004-03-16 2012-12-11 Medtronic, Inc. Detecting sleep to evaluate therapy
US8792982B2 (en) 2004-03-16 2014-07-29 Medtronic, Inc. Collecting posture information to evaluate therapy
US8335568B2 (en) 2004-03-16 2012-12-18 Medtronic, Inc. Controlling therapy based on sleep quality
US9623248B2 (en) 2004-03-16 2017-04-18 Medtronic, Inc. Collecting sleep quality information via a medical device
US7881798B2 (en) 2004-03-16 2011-02-01 Medtronic Inc. Controlling therapy based on sleep quality
US20070123758A1 (en) * 2004-03-16 2007-05-31 Medtronic, Inc. Determination of sleep quality for neurological disorders
US7908013B2 (en) 2004-03-16 2011-03-15 Medtronic, Inc. Collecting activity information to evaluate therapy
US7167743B2 (en) 2004-03-16 2007-01-23 Medtronic, Inc. Collecting activity information to evaluate therapy
US20050234514A1 (en) * 2004-03-16 2005-10-20 Heruth Kenneth T Collecting posture information to evaluate therapy
US20050222643A1 (en) * 2004-03-16 2005-10-06 Heruth Kenneth T Collecting activity information to evaluate therapy
US8055348B2 (en) 2004-03-16 2011-11-08 Medtronic, Inc. Detecting sleep to evaluate therapy
US8190253B2 (en) 2004-03-16 2012-05-29 Medtronic, Inc. Collecting activity information to evaluate incontinence therapy
US8447401B2 (en) 2004-03-16 2013-05-21 Medtronic, Inc. Collecting posture information to evaluate therapy
US8337431B2 (en) 2004-03-16 2012-12-25 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US8135473B2 (en) 2004-04-14 2012-03-13 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US8688221B2 (en) 2004-04-14 2014-04-01 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US20050245988A1 (en) * 2004-04-14 2005-11-03 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US8021299B2 (en) 2005-06-01 2011-09-20 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US20070015976A1 (en) * 2005-06-01 2007-01-18 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US20100113961A1 (en) * 2005-06-29 2010-05-06 St. Jude Medical Ab Medical device for determining the posture of patient
US8790254B2 (en) * 2005-06-29 2014-07-29 St. Jude Medical Ab Medical device for determining the posture of patient
US20070129622A1 (en) * 2005-12-02 2007-06-07 Medtronic, Inc. Wearable ambulatory data recorder
US20070129769A1 (en) * 2005-12-02 2007-06-07 Medtronic, Inc. Wearable ambulatory data recorder
US8444578B2 (en) 2005-12-02 2013-05-21 Medtronic, Inc. Wearable ambulatory data recorder
US8016776B2 (en) 2005-12-02 2011-09-13 Medtronic, Inc. Wearable ambulatory data recorder
US20120109251A1 (en) * 2006-03-23 2012-05-03 Valery Pavlovich Lebedev Transcranial electrostimulation device
US8744587B2 (en) 2006-03-24 2014-06-03 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US9592379B2 (en) 2006-03-24 2017-03-14 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US8317770B2 (en) 2006-04-06 2012-11-27 Medtronic, Inc. Systems and methods of identifying catheter malfunctions using pressure sensing
US7764996B2 (en) 2006-10-31 2010-07-27 Cardiac Pacemakers, Inc. Monitoring of chronobiological rhythms for disease and drug management using one or more implantable device
US8005540B2 (en) 2006-10-31 2011-08-23 Cardiac Pacemakers, Inc. Monitoring of chronobiological rhythms for disease and drug management using one or more implantable device
US8401636B2 (en) 2006-10-31 2013-03-19 Cardiac Pacemakers, Inc. Monitoring of chronobiological rhythms for disease and drug management using one or more implantable device
US8805493B2 (en) 2006-10-31 2014-08-12 Cardiac Pacemakers, Inc. Monitoring of chronobiological rhythms for disease and drug management using one or more implantable device
US8696588B2 (en) * 2006-12-07 2014-04-15 Dräger Medical GmbH Device and method for determining a respiration rate
US20080139955A1 (en) * 2006-12-07 2008-06-12 Drager Medical Ag & Co. Kg Device and method for determining a respiration rate
US9597032B2 (en) 2007-02-09 2017-03-21 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
US8323244B2 (en) 2007-03-30 2012-12-04 Medtronic, Inc. Catheter malfunction determinations using physiologic pressure
US20080243074A1 (en) * 2007-03-30 2008-10-02 Miesel Keith A Catheter malfunction determinations using physiologic pressure
US9044537B2 (en) 2007-03-30 2015-06-02 Medtronic, Inc. Devices and methods for detecting catheter complications
US20090082639A1 (en) * 2007-09-25 2009-03-26 Pittman Stephen D Automated Sleep Phenotyping
US9743841B2 (en) * 2007-09-25 2017-08-29 Ric Investments, Llc Automated sleep phenotyping
US20090156908A1 (en) * 2007-12-14 2009-06-18 Transoma Medical, Inc. Deriving Patient Activity Information from Sensed Body Electrical Information
US8180442B2 (en) 2007-12-14 2012-05-15 Greatbatch Ltd. Deriving patient activity information from sensed body electrical information
US20110015469A1 (en) * 2008-04-09 2011-01-20 Lotus Magnus, Llc. Brain stimulation systems and methods
US9149599B2 (en) 2008-04-09 2015-10-06 Lotus Magnus, Llc Brain stimulation systems and methods
US9984584B2 (en) 2008-04-09 2018-05-29 Lotus Magnus, Llc Brain stimulation systems and methods
US20100234697A1 (en) * 2008-04-29 2010-09-16 Lotus Magnus, Llc Systems, devices, and methods for monitoring a subject
US8644945B2 (en) 2008-07-11 2014-02-04 Medtronic, Inc. Patient interaction with posture-responsive therapy
US8447411B2 (en) 2008-07-11 2013-05-21 Medtronic, Inc. Patient interaction with posture-responsive therapy
US8437861B2 (en) 2008-07-11 2013-05-07 Medtronic, Inc. Posture state redefinition based on posture data and therapy adjustments
US8401666B2 (en) 2008-07-11 2013-03-19 Medtronic, Inc. Modification profiles for posture-responsive therapy
US9662045B2 (en) 2008-07-11 2017-05-30 Medtronic, Inc. Generation of sleep quality information based on posture state data
US8504150B2 (en) 2008-07-11 2013-08-06 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8515550B2 (en) 2008-07-11 2013-08-20 Medtronic, Inc. Assignment of therapy parameter to multiple posture states
US8515549B2 (en) 2008-07-11 2013-08-20 Medtronic, Inc. Associating therapy adjustments with intended patient posture states
US8332041B2 (en) 2008-07-11 2012-12-11 Medtronic, Inc. Patient interaction with posture-responsive therapy
US8583252B2 (en) 2008-07-11 2013-11-12 Medtronic, Inc. Patient interaction with posture-responsive therapy
US8323218B2 (en) 2008-07-11 2012-12-04 Medtronic, Inc. Generation of proportional posture information over multiple time intervals
US9592387B2 (en) 2008-07-11 2017-03-14 Medtronic, Inc. Patient-defined posture states for posture responsive therapy
US8326420B2 (en) 2008-07-11 2012-12-04 Medtronic, Inc. Associating therapy adjustments with posture states using stability timers
US8688225B2 (en) 2008-07-11 2014-04-01 Medtronic, Inc. Posture state detection using selectable system control parameters
US8315710B2 (en) 2008-07-11 2012-11-20 Medtronic, Inc. Associating therapy adjustments with patient posture states
US8708934B2 (en) 2008-07-11 2014-04-29 Medtronic, Inc. Reorientation of patient posture states for posture-responsive therapy
US8282580B2 (en) 2008-07-11 2012-10-09 Medtronic, Inc. Data rejection for posture state analysis
US9776008B2 (en) 2008-07-11 2017-10-03 Medtronic, Inc. Posture state responsive therapy delivery using dwell times
US8751011B2 (en) 2008-07-11 2014-06-10 Medtronic, Inc. Defining therapy parameter values for posture states
US8755901B2 (en) 2008-07-11 2014-06-17 Medtronic, Inc. Patient assignment of therapy parameter to posture state
US9560990B2 (en) 2008-07-11 2017-02-07 Medtronic, Inc. Obtaining baseline patient information
US8249718B2 (en) 2008-07-11 2012-08-21 Medtronic, Inc. Programming posture state-responsive therapy with nominal therapy parameters
US8231556B2 (en) 2008-07-11 2012-07-31 Medtronic, Inc. Obtaining baseline patient information
US9919159B2 (en) 2008-07-11 2018-03-20 Medtronic, Inc. Programming posture responsive therapy
US8219206B2 (en) 2008-07-11 2012-07-10 Medtronic, Inc. Dwell time adjustments for posture state-responsive therapy
US8209028B2 (en) 2008-07-11 2012-06-26 Medtronic, Inc. Objectification of posture state-responsive therapy based on patient therapy adjustments
US8886302B2 (en) 2008-07-11 2014-11-11 Medtronic, Inc. Adjustment of posture-responsive therapy
US8905948B2 (en) 2008-07-11 2014-12-09 Medtronic, Inc. Generation of proportional posture information over multiple time intervals
US8958885B2 (en) 2008-07-11 2015-02-17 Medtronic, Inc. Posture state classification for a medical device
US9440084B2 (en) 2008-07-11 2016-09-13 Medtronic, Inc. Programming posture responsive therapy
US8200340B2 (en) 2008-07-11 2012-06-12 Medtronic, Inc. Guided programming for posture-state responsive therapy
US9956412B2 (en) 2008-07-11 2018-05-01 Medtronic, Inc. Linking posture states for posture responsive therapy
US9050471B2 (en) 2008-07-11 2015-06-09 Medtronic, Inc. Posture state display on medical device user interface
US9327129B2 (en) 2008-07-11 2016-05-03 Medtronic, Inc. Blended posture state classification and therapy delivery
US8150531B2 (en) 2008-07-11 2012-04-03 Medtronic, Inc. Associating therapy adjustments with patient posture states
US9968784B2 (en) 2008-07-11 2018-05-15 Medtronic, Inc. Posture state redefinition based on posture data
US9272091B2 (en) 2008-07-11 2016-03-01 Medtronic, Inc. Posture state display on medical device user interface
US9545518B2 (en) 2008-07-11 2017-01-17 Medtronic, Inc. Posture state classification for a medical device
US20100042174A1 (en) * 2008-08-12 2010-02-18 Pacesetter, Inc. Selecting pacing site or sites based on cardio-pulmonary information
US8280517B2 (en) 2008-09-19 2012-10-02 Medtronic, Inc. Automatic validation techniques for validating operation of medical devices
US8257274B2 (en) 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
US8175720B2 (en) 2009-04-30 2012-05-08 Medtronic, Inc. Posture-responsive therapy control based on patient input
US9026223B2 (en) 2009-04-30 2015-05-05 Medtronic, Inc. Therapy system including multiple posture sensors
US9327070B2 (en) 2009-04-30 2016-05-03 Medtronic, Inc. Medical device therapy based on posture and timing
US8231555B2 (en) 2009-04-30 2012-07-31 Medtronic, Inc. Therapy system including multiple posture sensors
US8579834B2 (en) 2010-01-08 2013-11-12 Medtronic, Inc. Display of detected patient posture state
US9956418B2 (en) 2010-01-08 2018-05-01 Medtronic, Inc. Graphical manipulation of posture zones for posture-responsive therapy
US8388555B2 (en) 2010-01-08 2013-03-05 Medtronic, Inc. Posture state classification for a medical device
US9357949B2 (en) 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
US8758274B2 (en) 2010-01-08 2014-06-24 Medtronic, Inc. Automated adjustment of posture state definitions for a medical device
US9149210B2 (en) 2010-01-08 2015-10-06 Medtronic, Inc. Automated calibration of posture state classification for a medical device
US9174055B2 (en) 2010-01-08 2015-11-03 Medtronic, Inc. Display of detected patient posture state
US9566441B2 (en) 2010-04-30 2017-02-14 Medtronic, Inc. Detecting posture sensor signal shift or drift in medical devices
US9069380B2 (en) 2011-06-10 2015-06-30 Aliphcom Media device, application, and content management using sensory input
WO2013002846A1 (en) 2011-06-27 2013-01-03 Medtronic, Inc. Devices and methods for detecting catheter complications
US9907959B2 (en) 2012-04-12 2018-03-06 Medtronic, Inc. Velocity detection for posture-responsive therapy
US9737719B2 (en) 2012-04-26 2017-08-22 Medtronic, Inc. Adjustment of therapy based on acceleration
US9333351B2 (en) 2013-12-16 2016-05-10 Pacesetter, Inc. Neurostimulation method and system to treat apnea

Also Published As

Publication number Publication date Type
US20050209511A1 (en) 2005-09-22 application
DE602005017755D1 (en) 2009-12-31 grant
US7491181B2 (en) 2009-02-17 grant
US20090118599A1 (en) 2009-05-07 application
EP1732442A1 (en) 2006-12-20 application
EP1732442B1 (en) 2009-11-18 grant
US8337431B2 (en) 2012-12-25 grant
WO2005089647A1 (en) 2005-09-29 application

Similar Documents

Publication Publication Date Title
US7591265B2 (en) Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7228167B2 (en) Method and apparatus for detecting vagus nerve stimulation
US20090264967A1 (en) Timing therapy evaluation trials
US20110282416A1 (en) Systems for patient control of implantable medical device therapy
US7469697B2 (en) Feedback system and method for sleep disordered breathing therapy
US6641542B2 (en) Method and apparatus to detect and treat sleep respiratory events
US7957809B2 (en) Closed-loop therapy adjustment
US20100010390A1 (en) Dwell time adjustments for posture state-responsive therapy
US20070260147A1 (en) System and method for monitoring cardiac signal activity in patients with nervous system disorders
US20050107838A1 (en) Subcutaneous cardiac rhythm management with disordered breathing detection and treatment
US8209028B2 (en) Objectification of posture state-responsive therapy based on patient therapy adjustments
US7155281B1 (en) Complimentary activity sensor network for disease monitoring and therapy modulation in an implantable device
US20090112281A1 (en) Medical device configuration based on sensed brain signals
US7319899B2 (en) Sensing techniques for implantable medical devices
US8200340B2 (en) Guided programming for posture-state responsive therapy
US20050042589A1 (en) Sleep quality data collection and evaluation
US6190324B1 (en) Implantable medical device for tracking patient cardiac status
US7160252B2 (en) Method and apparatus for detecting respiratory disturbances
US20050080348A1 (en) Medical event logbook system and method
US20120165684A1 (en) Systems and Methods for Heart and Activity Monitoring
US6066163A (en) Adaptive brain stimulation method and system
US20060079802A1 (en) Method and apparatus to detect and monitor the frequency of obstructive sleep apnea
US20060036294A1 (en) Patient compliance management device and method
US20050113710A1 (en) Implantable device employing movement sensing for detecting sleep-related disorders
US20070260286A1 (en) System and method for utilizing brain state information to modulate cardiac therapy

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HERUTH, KENNETH T.;MIESEL, KEITH A.;REEL/FRAME:016705/0282

Effective date: 20050512